SOLVENT-FREE FORMULATIONS OF LOW MELTING POINT ACTIVE SUBSTANCES

Description

[0001] The present invention relates to solvent-free aqueous suspension concentrates, as well as solvent-free solid, water-dispersible formulations containing one or more low-melting active ingredients, and to methods for their preparation. The formulations according to the invention are suitable for use in plant protection.

[0002] Active ingredients can, in principle, be formulated in many different ways, but the properties of the active ingredients and the type of formulation can pose problems regarding manufacturability, stability, applicability, and efficacy. Furthermore, certain formulations are more advantageous than others for economic and environmental reasons.

[0003] Water-based formulations generally have the advantage of requiring little or no organic solvents.

[0004] On the other hand, there is a general need for highly concentrated formulations of active ingredients because the higher concentration offers numerous advantages. For example, highly concentrated formulations require less packaging than low-concentration formulations. This, in turn, reduces the effort required for production, transport, and storage. Furthermore, the preparation of spray solutions used in agriculture is simplified by the smaller quantities of, for example, plant protection products that need to be handled, such as during filling and mixing. In addition, water-concentrated formulations are usually not only more concentrated than organic, solvent-based formulations, but also more environmentally friendly because they are solvent-free. Water-dispersible granule formulations (WG) are also highly concentrated.Both water-dispersible granules and suspension concentrates (SC) are therefore preferred from an economic and ecological point of view.

[0005] However, some substances, such as the herbicide safener, cannot be added directly to water due to their low and broad melting range and amorphous structure. Therefore, they must first be dissolved or formulated in organic solvents. They are then formulated, for example, as organic dispersions, aqueous emulsions, suspensions, capsule suspensions, or emulsion concentrates, in which the low-melting active ingredient is dissolved or emulsified. A disadvantage of this approach is that the addition of organic solvents does not result in aqueous dispersions, but rather in aqueous emulsions or suspensions, which are significantly less stable during storage and usually have lower concentrations than pure aqueous dispersions.When the technical concentrate is further processed into a water-dispersible granulate, up to 20 wt% of the commonly used mineral oils as solvents (such as Solvesso ®< 200 ND from ExxonMobil) remain in the final product.

[0006] Water-dispersible granules available on the market can suffer from quality defects. These include: poor dispersibility / suspenseability, unacceptable sieve residues, poor flowability or compaction of the bulk material, clogging of filters and nozzles, or stubborn soiling of spraying equipment.

[0007] Overall, the liquid formulations known from the prior art that contain mefenpyr-diethyl or cloquintocet-mexyl as herbicide safeners are emulsion concentrates or oil dispersions. Purely aqueous dispersions or resulting granules of these herbicide safeners are not known to date.

[0008] Herbicide safeners (such as mefenpyr-diethyl or cloquintocet-mexyl) are often present as esterified acids, which, in their technical grade, are available as solidified melts with a limited melting range. Only conversion into a powder through purification with targeted crystallization would allow the direct addition of the resulting powder to the aqueous phase. However, this purification process is not only technically complex and expensive, but these particles are also only weakly stabilized during milling and therefore tend to clump together.

[0009] Higher concentration aqueous suspension concentrates are already known from the prior art, such as those of sulfur (EP-A-0220655) and metamitron (EP-A-0620971), or mixtures of formaldehyde condensation products, preferably lignosulfonates and wetting agents.

[0010] WO-A 91 / 07874 discloses formulations containing mefenpyr diethyl. However, the aqueous dispersion concentrates mentioned therein contain organic solvent in an amount of 77% by weight, meaning they are suspoemulsions.

[0011] US Patent 5,785,976 and WO-A 03 / 034822 describe melt dispersions; however, in these cases, the substances are in an amorphous state at the nanometer scale. The pre-concentrates are shock-cooled, resulting in a non-controlled, homogeneous crystalline dispersion. Furthermore, milling with other dispersed active ingredients is not possible because the particles would clump together.

[0012] EP 1319336 describes a process for the production of a solvent-free suspension of low-melting, water-insoluble solid agrochemical active ingredients.

[0013] A disadvantage of the formulations known from the prior art (whether as suspension concentrate or water-dispersible granules) is that large quantities of organic solvents, which are undesirable for the environment and the user, must be used to dissolve the safener.

[0014] There is therefore still a need for new formulations in the form of aqueous dispersions containing a low-melting herbicide safener with a low melting temperature range, produced without organic solvents, as well as for solid, water-dispersible granules that can be produced from them. Furthermore, the water-dispersible granules should not agglomerate or clump together. The object of the present invention was therefore to provide aqueous, solvent-free formulations (SC) and solid, water-dispersible formulations (WG) based on a low-melting herbicide safener with a low melting temperature range.The present invention relates to a process for producing aqueous, solvent-free formulations, characterized in that, in a first step, at least one agrochemical active ingredient a) with a melting point range between 50°C and 80°C is melted, the melt is then added to water while stirring, the water containing at least one ionic and / or non-ionic dispersing agent b), and in a second step, the mixture is cooled below the melting point of the active ingredient. According to the invention, the active ingredient a) is mefenpyr-diethyl.

[0015] In the method according to the invention, the water has a temperature between 0°C and 40°C, preferably between 5°C and 20°C.

[0016] In the second step of the process according to the invention, stirring is carried out during cooling for a period of 5 minutes to 24 hours, preferably for 10 minutes to 15 hours, provided that mefenpyr-diethyl crystals can be detected under a microscope at a concentration of at least 90 wt%, based on the amount of mefenpyr-diethyl used. The crystalline active ingredient must no longer exhibit an amorphous structure.

[0017] In the process according to the invention, in the first step, component a) is added to an aqueous solution containing an ionic dispersant b1), a carrier material c1), and a filler c2). Preferably, in this embodiment (I), the crystallized product is milled in a third step, with at least 50% of the particles having a size of 1 to 5 µm (d50, bulk particles). The formulations obtained in this way are technical concentrates (TC). It is also possible in the process according to the invention to add a non-ionic dispersant b2) in addition to the ionic dispersant b1). According to the invention, the carrier material c1) is a highly absorbent carrier from the group of silicas with an absorption capacity of at least 200 g of dibutyl phthalate per 100 g of carrier material.

[0018] Technical concentrates (TC) obtainable according to the inventive method are also the subject of the present invention.

[0019] Preferably, in the third step of the inventive process (I), the water is removed from the TK. Particularly preferably, the water is removed using fluidized bed technology. The products obtained in this way are water-dispersible granules (WG). Therefore, the present invention also relates to water-dispersible granules (WG) obtainable by the inventive process.

[0020] Fluidized bed technology is a common process for producing water-dispersible granules (WG). The principle involves injecting the partial concentrate into a fluidized bed chamber. At the elevated temperature within the chamber, the aqueous component is dried and dispersed. This is achieved by injecting a heating gas, such as nitrogen. The dissolved or dispersed substances then agglomerate to form solid granules.

[0021] In a further preferred embodiment (II) of the process according to the invention, in a first step, component a) is added to an aqueous solution containing an ionic dispersant b1), a non-ionic dispersant b2), and a carrier material c1). Preferably, in this embodiment (II), the crystallized product is milled in a third step, wherein at least 50% of the particles have a size of 1 to 5 µm (d50, bulk particles), and an organic thickener d1) is added after milling. The formulations obtainable with embodiment (II) are water-dispersible suspension concentrates (SC).

[0022] Also part of the present invention are water-dispersible suspension concentrates (SC) obtainable according to the inventive method.

[0023] Grinding can be carried out according to methods known in the prior art, e.g. by wet grinding of the components in bead mills (such as discontinuous bead mills or continuous bead mills), or colloid mills (such as tooth colloid mills).

[0024] The water content in the formulations according to the invention can generally be 25 to 98 wt.%, preferably 35 to 85 wt.%. The term "wt.%" (weight percent) used here and throughout this description, unless otherwise defined, refers to the relative weight of the respective component in relation to the total weight of the formulation or partial concentrate. The formulation may typically contain residues of organic solvents from the additives of 0 to 5%. Solvent-free within the meaning of the invention means that component a) is added in liquid form without solvent and is not present in dissolved form in the finished dispersion, but rather forms undissolved crystals (dispersion).

[0025] Suitable active ingredients a) are all agrochemical active ingredients that have a melting temperature range between 50°C and 80°C in the solid state.

[0026] For example, the following are listed as active ingredients a) with a melting point range between 50 and 80°C: Anilofos, Acephate, Benfluralin, Bifenthrin, Bupirimate, Butralin, Chloroacetic acid, Cyfluthrin, Cypermethrin, Demeton-S-methylsulfone, Dimethametryn, Dimethoate, Dioxabenzofos, Diphenylamine, Dithiopyr, Dodemorphacetate, Esfenvalerate, Ethalfluralin, Ethofumesate, Fenazaquin, Fenitropane, Fenoxycarb, Fenuron-TCA, Fenvalerate, Fluoroglycofen-ethyl, Flupyradifurone, Flurazole, Flurochloridone, Fluroxypyr-meptyl, Flusilazole, Furalaxyl, Haloxyfop-etotyl, Haloxyfop-methyl, Imazalil, Ioxynil octanoate, Isoprothiolane, Metalaxyl Methomyl, Methoprotryne, Monocrotophos, Nitrapyrin, Nitrothal-isopropyl, Penconazole, Pendimethalin, Permethrin, Propamocarb hydrochloride, Propaquizafop, Pyrazophos, Quizalofop-P-tefuryl, Resmethrin, Trichloroacetic acid, Tetramethrin, Thiofanox, Triflumizole, Pyridaphenthione, 2-Phenylphenol, Dimethylvinphos, beta-cypermethrin, famphur, clodinafop propargyl,Cloquintocet-mexyl, Triazamate, Tebufenpyrad, Pyrimidifen, Aldrin, Bromophos, Dialifos, Pyriminobac-methyl, Mefenpyr-diethyl, Benzoylprop, Benzoylprop-ethyl, Binapacryl, Camphechlor, Chlorfenethol, Chlorfenprop, Chlorfenprop-methyl, Chlorphoxim, Crufomate, Cyometrinil, With (S)-cis-verbenol, fenoxanil, pyraclostrobin, Trifloxystrobin, cyflufenamide, gamma-cyhalothrin, proquinazide, 2,6-diisopropylnaphthalene, isotianil.,

[0027] Preferred active ingredients are a) compounds that exist as esters and have a melting temperature range. Active ingredients from the herbicide safener group are particularly preferred. Mefenpyr diethyl or cloquintocet-mexyl are especially preferred.

[0028] According to the invention, the active ingredient is a) mefenyl diethyl. These formulations are preferably used in cereal crops.

[0029] The proportion of active ingredients (component a) in the formulations according to the invention is 0.5 to 40 wt.%, preferably 0.5 to 30 wt.%, particularly preferably 0.5 to 15 wt.% and most preferably 1 to 8 wt.%.

[0030] Suitable anionic dispersants b1) such as emulsifiers, surfactants, wetting agents and dispersants are, for example, alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates and mixtures thereof, such as the salts of alkylsulfonic or alkylphosphoric acids, as well as alkylarylsulfonic or alkylarylphosphoric acids, diphenylsulfonates, alpha-olefin sulfonates, lignosulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl and tridecylbenzenes, sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates include sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates include phosphate esters.Examples of carboxylates include alkyl carboxylates and carboxylated alcohol or alkylphenol ethoxylates. Also suitable are the group of anionic emulsifiers of alkali metal, alkaline earth metal, and ammonium salts of polystyrenesulfonic acids, salts of polyvinylsulfonic acids, salts of alkylnaphthalenesulfonic acids, salts of alkylnaphthalenesulfonic acid-formaldehyde condensation products, and salts of condensation products of naphthalenesulfonic acid, phenolsulfonic acid, and formaldehyde. Examples include calcium dodecylbenzenesulfonate such as Rhodocal® < 70 / B (Solvay), phenylsulfonate CA100 (Clariant), and isopropylammonium dodecylbenzenesulfonates such as Atlox® < 3300B (Croda).

[0031] Other typical examples include Phenylsulfonate CA (Ca-dodecylbenzenesulfonate), Soprophor®< types (possibly esterified derivatives of tristyrylphenol ethoxylates), Emulsogen®< 3510 (alkylated EO / PO copolymer), Emulsogen®< EL 400 (ethoxylated castor oil), Tween®< types (fatty acylated sorbitan ethoxylates), Calsogen®< AR 100 (Ca-dodecylbenzenesulfonate). Preferred are combinations of salts of alkylated aromatic sulfonic acids, such as phenylsulfonate Ca and / or Calsogen®< AR 100, with alkylated copolymers of ethylene and propylene oxide, such as Emulsogen®< 3510. Particularly preferred are combinations of salts of dodecylbenzenesulfonic acid, such as Calsogen®< AR 100, with alkylated copolymers of ethylene and propylene oxide, such as Emulsogen®< 3510.

[0032] Examples of other anionic emulsifiers b1) from the naphthalenesulfonate group are Galoryl ®< MT 800 (sodium dibutylnaphthalenesulfonic acid), Morwet ®< IP (sodium diisopropylnaphthalenesulfonate) and Nekal ®< BX (alkylnaphthalenesulfonate). Examples of anionic surfactants from the group of condensation products of naphthalenesulfonates with formaldehyde are Galoryl®< DT 201 (naphthalenesulfonic acid hydroxypolymer with formaldehyde and methylphenol sodium salt), Galoryl®< DT 250 (condensation product of phenol and naphthalenesulfonates), Reserve®< C (condensation product of phenol and naphthalenesulfonates), or Morwet®< D-425, Tersperse®< 2020. Preferably, naphthalenesulfonates 1,2-substituted with di-butyl or di-isobutyl are used, such as products like Galoryl®< MT 800 (CFPI-Nufarm) and Nekal®< BX (BASF).Other typical surfactants are Soprophor ®< 3D33, Soprophor ®< 4D384, Soprophor ®< BSU, Soprophor ®< CY / 8 (Solvay) and Hoe ®< S3474 and in the form of the Sapogenat ®< T products (Clariant), for example Sapogenat ®< T 100.

[0033] Suitable nonionic dispersants (b2) such as emulsifiers, wetting agents, surfactants, and dispersants include common surface-native substances found in formulations of agrochemical active ingredients. Examples include ethoxylated nonylphenols, reaction products of linear or branched alcohols with ethylene oxide and / or propylene oxide, ethylene oxide-propylene oxide block copolymers, and end-capped and non-end-capped alkoxylated linear and branched, saturated and unsaturated alcohols (e.g.,Butoxypolyethylenepropylene glycols), reaction products of alkylphenols with ethylene oxide and / or propylene oxide, ethylene oxide-propylene oxide block copolymers, polyethylene glycols and polypropylene glycols, furthermore fatty acid esters, fatty acid polyglycol ether esters, alkyl sulfonates, alkyl sulfates, aryl sulfates, ethoxylated arylalkylphenols, such as tristyrylphenol ethoxylate with an average of 16 ethylene oxide units per molecule, furthermore ethoxylated and propoxylated arylalkylphenols as well as sulfated or phosphatized arylalkylphenol ethoxylates or -ethoxy- and -propoxylates. Tristyrylphenol alkoxylates and fatty acid polyglycol ether esters are particularly preferred. Tristyrylphenol ethoxylates, tristyrylphenol ethoxy-propoxylates and castor oil polyglycol ether esters, each individually or in mixtures, are especially preferred. In addition, additives such as surfactants or fatty acid esters may be used to improve biological efficacy.Suitable non-ionic emulsifiers b2) are, for example, Soprophor ®< 796 / P, Lucramul ®< CO30, Lucramul ®< HOT, Lucramul ®< PSI 100 or Synperonic ®< T304.

[0034] Suitable non-ionic dispersants (b2) may also be selected from the group containing polyvinylpyrrolidone (PVP), polyvinyl alcohol, PVP-dimethylaminoethyl methacrylate copolymer, butylated PVP, vinyl chloride-vinyl acetate copolymer, and partially hydrolyzed vinyl acetate, phenolic resins, modified cellulose types such as Luviskol® (polyvinylpyrrolidone), Mowiol® (polyvinyl alcohol), or modified cellulose. Polyvinylpyrrolidone types are preferred, and low molecular weight types such as Luviskol® K30 or Sokalan® K30 are particularly preferred.

[0035] Other non-ionic emulsifiers b2) from the group of di- and tri-block copolymers of alkylene oxides include, for example, compounds based on ethylene and propylene oxides, with average molar masses between 200 and 10000, preferably 1000 to 4000 g / mol, wherein the mass fraction of the polyethoxylated block varies between 10 and 80%, such as Synperonic®< PE series (Uniqema), Pluronic®< PE series (BASF), VOP®< 32- or Genapol®< PF series (Clariant).

[0036] The proportion of the required anionic dispersing aids b1) in the technical concentrates according to the invention is 2 to 35 wt.%, preferably 3 to 30 wt.%, preferably 5 to 25 wt.% and most preferably 10 to 20 wt.%.

[0037] The proportion of the required anionic dispersing aids b1) in the suspension concentrates according to the invention is 0.1 to 10 wt.%, preferably 0.2 to 7 wt.% and most preferably 0.3 to 4 wt.%.

[0038] The proportion of the required non-ionic dispersing aids b2) in the suspension concentrates according to the invention is 1 to 15 wt.%, preferably 2 to 10 wt.% and most preferably 2.5 to 8 wt.%.

[0039] Also described are solvent-free, water-dispersible technical concentrates (TCs) containing one or more active ingredients a) with a melting temperature range between 50 and 80°C, one or more anionic emulsifiers b1), one or more non-ionic emulsifiers b2), at least one or more carrier materials c1) and at least one filler c2).

[0040] Also described are solvent-free, water-dispersible suspension concentrates (SCs) containing one or more active ingredients a) with a melting temperature range between 50 and 80°C, one or more anionic emulsifiers b1), one or more non-ionic emulsifiers b2), a carrier material c1) and at least one or more thickeners d).

[0041] Suitable carrier materials c1) are selected from the group of highly absorbent carriers with an absorption capacity of at least 200 g of dibutyl phthalate per 100 g of carrier material.

[0042] Highly absorbent carriers according to the invention (c1) are silicas such as Sipernat® types (synthetic precipitated silica of high absorbency) and pyrogenic silica (Aerosil® types). Precipitated silica is preferred.

[0043] The proportion of the required fillers c1) in the TKs according to the invention is 0.1 to 10 wt.%, preferably 0.3 to 8 wt.% and most preferably 1 to 7 wt.%.

[0044] The proportion of the required fillers c1) in the SCs according to the invention is 0.05 to 10 wt.%, preferably 0.1 to 8 wt.%, preferably 0.3 to 5 and most preferably 0.5 to 3 wt.%.

[0045] The fillers c2) in the WG's or TK's according to the invention are selected from the group containing minerals, carbonates, sulfates and phosphates of alkaline earth and alkali metals, such as calcium carbonate, polymeric carbohydrates, framework silicates, such as low-absorption precipitated silicas and natural framework silicates, such as kaolin. Typical examples of suitable fillers c2) are, for example, Agsorb® < LVM® < -GA (attapulgite), Harborlite® < 300 (perlite), Collys® < HV (modified starch), Omya® < -chalk (calcium carbonate), Kaolin® < Tec 1 (kaolin, aluminum hydrosilicate), Steamic® < OOS (talc, magnesium silicate). Preferred for c2) are natural framework silicates and calcium carbonate types such as Omya ®< -chalk (calcium carbonate), Kaolin Tec 1 ®< (kaolin) and Harborlite ®< 300 (perlite), especially preferred are natural framework silicates such as Kaolin ®< , Tec ®< 1 (kaolin, aluminum hydrosilicate) and Harborlite ®< 300 (perlite).Kaolin and calcium carbonate are particularly preferred for c2).

[0046] The proportion of the required fillers c2) in the TK's or WG's according to the invention is 2 to 35 wt.%, preferably 3 to 30 wt.%, preferably 5 to 25 wt.% and most preferably 10 to 20 wt.%.

[0047] Suitable thickeners d) include organic thickeners d1) and inorganic thickeners d2).

[0048] Organic thickeners (d1) are available as naturally occurring organic or biotechnologically modified, or as synthetic organic thickeners. Typical synthetic thickeners include Rheostrux® (Croda), Thixin®, and the Thixatrol® series (Elementis). These are typically acrylate-based. Typical organic thickeners are based on xanthan gum or cellulose (such as hydroxyethyl or carboxymethylcellulose) or a combination thereof. Other typical examples are lignin-based (such as lignosulfonates, Borresperse® NA, REAX® 88, or Kraftsperse 25 S). Naturally modified xanthan gum-based thickeners are preferred. Typical examples include Rhodopol® (Solvay), Kelzan® (Kelco Corp.), and Satiaxane® (Cargill).

[0049] The proportion of the organic thickeners d1) in the SCs according to the invention is less than or equal to 5 wt.%, preferably 0.01 to 1.0 wt.%, particularly preferably 0.01 to 0.6 wt.%, most preferably 0.05 to 0.5 wt.% and most preferably 0.1 to 0.3 wt.%. % .

[0050] Suitable inorganic thickeners d2) include, for example, modified natural silicates such as chemically modified bentonites, hectorites, attapulgites, montmorillonites, smectites or other silicate minerals such as Bentone ®< (Elementis), Attagel ®< (Engelhard), Agsorb ®< (Oil-Dri Corporation) or Hectorite ®< (Akzo Nobel) or the Van Gel series (RT Vanderbilt).

[0051] The proportion of inorganic thickeners d2) in the SCs according to the invention is 0 to 5 wt.%, preferably 0.1 to 3 wt.%, particularly preferably 0.2 to 1.5 wt.%, most preferably 0.3 to 1.5 wt.% and most preferably 0.4 to 1.3 wt.%.

[0052] A mixture of thickeners d1) and d2) is preferably used. The use of exclusively organic thickeners d1) is particularly preferred. Thickeners d1) based on xanthan gum (such as Rhodopol® from Solvay) are especially preferred.

[0053] Suitable agrochemical active ingredients (component e) that may be added to component a) include herbicides, fungicides, insecticides, plant growth regulators, safeners and the like.

[0054] Fungizide Wirkstoffe sind z.B. 1) Inhibitoren der Ergosterol-Biosynthese, beispielsweise (1.001) Cyproconazol, (1.002) Difenoconazol, (1.003) Epoxiconazol, (1.004) Fenhexamid, (1.005) Fenpropidin, (1.006) Fenpropimorph, (1.007) Fenpyrazamin, (1.008) Fluquinconazol, (1.009) Flutriafol, (1.010) Imazalil, (1.011) Imazalil Sulfat, (1.012) Ipconazol, (1.013) Metconazol, (1.014) Myclobutanil, (1.015) Paclobutrazol, (1.016) Prochloraz, (1.017) Propiconazol, (1.018) Prothioconazol, (1.019) Pyrisoxazol, (1.020) Spiroxamin, (1.021) Tebuconazol, (1.022) Tetraconazol, (1.023) Triadimenol, (1.024) Tridemorph, (1.025) Triticonazol, (1.026) (1R,2S,5S)-5-(4-Chlorbenzyl)-2-(chlormethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.027) (1S,2R,5R)-5-(4-Chlorbenzyl)-2-(chlormethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.028) (2R)-2-(1-Chlorcyclopropyl)-4-[(1R)-2,2-dichlorcyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1.029) (2R)-2-(1-Chlorcyclopropyl)-4-[(1S)-2,2-dichlorcyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.030) (2R)-2-[4-(4-Chlorphenoxy)-2-(trifluormethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.031) (2S)-2-(1-Chlorcyclopropyl)-4-[(1R)-2,2-dichlorcyclopropyl]-1-(1H-1,2,4-triazol-1 -yl)butan-2-ol, (1.032) (2S)-2-(1-Chlorcyclopropyl)-4-[(1S)-2,2-dichlorcyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.033) (2S)-2-[4-(4-Chlorphenoxy)-2-(trifluormethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.034) (R)-[3-(4-Chlor-2-fluorphenyl)-5-(2,4-difluorphenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.035) (S)-[3-(4-Chlor-2-fluorphenyl)-5-(2,4-difluorphenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.036) [3-(4-Chlor-2-fluorphenyl)-5-(2,4-difluorphenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (1.037) 1-({(2R,4S)-2-[2-Chlor-4-(4-chlorphenoxy)phenyl] -4-methyl-1,3-dioxolan-2-yl} methyl)-1H-1,2,4-triazol, (1.038) 1-({(2S,4S)-2-[2-Chlor-4-(4-chlorphenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazol, (1.039) 1- {[3-(2-Chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-1H-1 ,2,4-triazol-5-yl-thiocyanat, (1.040) 1-{[rel(2R,3R)-3-(2-Chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl-thiocyanat, (1.041) 1-{[rel(2R,3S)-3-(2-Chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol-5-yl-thiocyanat, (1.042) 2-[(2R,4R,5R)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.043) 2-[(2R,4R,5S)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.044) 2-[(2R,4S,5R)-1-(2,4-Dichlorophenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.045) 2-[(2R,4S,SS)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.046) 2-[(2S,4R,5R)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.047) 2-[(2S,4R,5S)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.048) 2-[(2S,4S,5R)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.049) 2-[(2S,4S,5S)-1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.050) 2-[1-(2,4-Dichlorphenyl)-5-hydroxy-2,6,6-trimethylheptan-4-yl]-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.051) 2-[2-Chlor-4-(2,4-dichlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.052) 2-[2-Chlor-4-(4-chlorphenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.053) 2-[4-(4-Chlorphenoxy)-2-(trifluormethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.054) 2- [4-(4-Chlorphenoxy)-2-(trifluormethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)pentan-2-ol, (1.055) 2-[4-(4-Chlorphenoxy)-2-(trifluormethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.056) 2-{ [3-(2-Chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.057) 2-{[rel(2R,3R)-3-(2-Chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.058) 2-{[rel(2R,3S)-3-(2-Chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-thion, (1.059) 5-(4-Chlorbenzyl)-2-(chlormethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.060) 5-(Allylsulfanyl)-1-{[3-(2-chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol, (1.061) 5-(Allylsulfanyl)-1-{[rel(2R,3R)-3-(2-chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol, (1.062) 5-(Allylsulfanyl)-1-{[rel(2R,3S)-3-(2-chlorphenyl)-2-(2,4-difluorphenyl)oxiran-2-yl]methyl}-1H-1,2,4-triazol, (1.063) N'-(2,5-Dimethyl-4-{[3-(1,1,2,2-tetrafluorethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamid, (1.064) N'-(2,5-Dimethyl-4-{[3-(2,2,2-trifluorethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamid, (1.065) N'-(2,5-Dimethyl-4-{ [3-(2,2,3,3-tetrafluorpropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamid, (1.066) N'-(2,5-Dimethyl-4-{ [3-(pentafluorethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidoformamid, (1.067) N'-(2,5-Dimethyl-4-{3-[(1,1,2,2-tetrafluorethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamid, (1.068) N'-(2,5-Dimethyl-4-{3-[(2,2,2-trifluorethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamid, (1.069) N'-(2,5-Dimethyl-4-{3-[(2,2,3,3-tetrafluorpropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamid, (1.070) N'-(2,5-Dimethyl-4-{3-[(pentafluorethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamid, (1.071) N'-(2,5-Dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylimidoformamid, (1.072) N'-(4-{ [3-(Difluormethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamid, (1.073) N'-(4-{ 3-[(Difluormethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamid, (1.074) N'-[5-Brom-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylimidoformamid, (1.075) N'-{4-[(4,5-Dichlor-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylimidoformamid, (1.076) N'-{5-Brom-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl} -N-ethyl-N-methylimidoformamid, (1.077) N'-{5-Brom-6-[(1S)-1-(3,5-difluorphenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamid, (1.078) N'-{5-Brom-6-[(cis-4-isopropylcyclohexyl)oxy] -2-methylpyridin-3-yl} -N-ethyl-N-methylimidoformamid, (1.079) N'- {5-Brom-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidoformamid, (1.080) N'-{5-Bromo-6-[1-(3 ,5-difluorphenyl)ethoxy] -2-methylpyridin-3-yl} -N-ethyl-N-methylimidoformamid, (1.081) Mefentrifluconazole, (1.082) Ipfentrifluconazole. . 2) Inhibitoren der Atmungskette am Komplex I oder II for example (2.001) Benzovindiflupyr, (2.002) Bixafen, (2.003) Boscalid, (2.004) Carboxin, (2.005) Fluopyram, (2.006) Flutolanil, (2.007) Fluxapyroxad, (2.008) Furametpyr, (2.009) Isofetamid, (2.010) Isopyrazam (anti-epimers Enantiomer 1R,4S,9S), (2.011) Isopyrazam (anti-epimers Enantiomer 1S,4R,9R), (2.012) Isopyrazam (anti-epimers Racemat 1RS,4SR,9SR), (2.013) Isopyrazam (Mischung des syn-epimeren Razemates 1RS,4SR,9RS und des anti-epimeren Racemates 1RS,4SR,9SR), (2.014) Isopyrazam (syn-epimeres Enantiomer 1R,4S,9R), (2.015) Isopyrazam (syn-epimeres Enantiomer 1S,4R,9S), (2.016) Isopyrazam (syn-epimeres Racemat 1RS,4SR,9RS), (2.017) Penflufen, (2.018) Penthiopyrad, (2.019) Pydiflumetofen, (2.020) Pyraziflumid, (2.021) Sedaxane, (2.022) 1,3-Dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazol-4-carboxamid, (2.023) 1,3-Dimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.024) 1,3-Dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid, (2.025) 1-Methyl-3-(trifluormethyl)-N-[2'-(trifluormethyl)biphenyl-2-yl]-1H-pyrazol-4-carboxamid, (2.026) 2-Fluor-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamid, (2.027) 3-(Difluormethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazol-4-carboxamid, (2.028) 3-(Difluormethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid, (2.029) 3-(Difluormethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid, (2.030) 3-(Difluormethyl)-N-(7-fluor-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazol-4-carboxamid, (2.031) 3-(Difluormethyl)-N-[(3R)-7-fluor-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazol-4-carboxamid, (2.032) 3-(Difluoromethyl)-N-[(3S)-7-fluor-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazol-4-carboxamid, (2.033) 5,8-Difluor-N-[2-(2-fluor-4-{ [4-(trifluormethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amin, (2.034) N-(2-Cyclopentyl-5-fluorbenzyl)-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.035) N-(2-tert-Butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.036) N-(2-tert-Butylbenzyl)-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.037) N-(5-Chlor-2-ethylbenzyl)-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.038) N-(5-Chlor-2-isopropylbenzyl)-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.039) N-[(1R,4S)-9-(Dichlormethylen)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluormethyl)-1-methyl-1H-pyrazol-4-carboxamid, (2.040) N-[(1S,4R)-9-(Dichlormethylen)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluormethyl)-1-methyl-1H-pyrazol-4-carboxamid, (2.041) N-[1-(2,4-Dichlorphenyl)-1-methoxypropan-2-yl]-3-(difluormethyl)-1-methyl-1H-pyrazol-4-carboxamid, (2.042) N-[2-Chlor-6-(trifluormethyl)benzyl]-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.043) N-[3-Chlor-2-fluor-6-(trifluormethyl)benzyl]-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.044) N-[5-Chlor-2-(trifluormethyl)benzyl]-N-cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.045) N-Cyclopropyl-3-(difluormethyl)-5-fluor-1-methyl-N-[5-methyl-2-(trifluormethyl)benzyl]-1H-pyrazol-4-carboxamid, (2.046) N-Cyclopropyl-3-(difluormethyl)-5-fluor-N-(2-fluor-6-isopropylbenzyl)-1-methyl-1H-pyrazol-4-carboxamid, (2.047) N-Cyclopropyl-3-(difluormethyl)-5-fluor-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazol-4-carboxamid, (2.048) N-Cyclopropyl-3-(difluormethyl)-5-fluor-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazol-4-carbothioamid, (2.049) N-Cyclopropyl-3-(difluoromethyl)-5-fluor-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazol-4-carboxamid, (2.050) N-Cyclopropyl-3-(difluormethyl)-5-fluor-N-(5-fluor-2-isopropylbenzyl)-1-methyl-1H-pyrazol-4-carboxamid, (2.051) N-Cyclopropyl-3-(difluormethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.052) N-Cyclopropyl-3-(difluormethyl)-N-(2-ethyl-5-fluorbenzyl)-5-fluor-1-methyl-1H-pyrazol-4-carboxamid, (2.053) N-Cyclopropyl-3-(difluormethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluor-1-methyl-1H-pyrazole-4-carboxamid, (2.054) N-Cyclopropyl-N-(2-cyclopropyl-5-fluorbenzyl)-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazole-4-carboxamid, (2.055) N-Cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazole-4-carboxamid, (2.056) N-Cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluormethyl)-5-fluor-1-methyl-1H-pyrazole-4-carboxamid. 3) Inhibitoren der Atmungskette am Komplex III, beispielsweise (3.001) Ametoctradin, (3.002) Amisulbrom, (3.003) Azoxystrobin, (3.004) Coumethoxystrobin, (3.005) Coumoxystrobin, (3.006) Cyazofamid, (3.007) Dimoxystrobin, (3.008) Enoxastrobin, (3.009) Famoxadon, (3.010) Fenamidon, (3.011) Flufenoxystrobin, (3.012) Fluoxastrobin, (3.013) Kresoxim-Methyl, (3.014) Metominostrobin, (3.015) Orysastrobin, (3.016) Picoxystrobin, (3.017) Pyraclostrobin, (3.018) Pyrametostrobin, (3.019) Pyraoxystrobin, (3.020) Trifloxystrobin (3.021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-Fluor-2-phenylvinyl]oxy}phenyl)ethyliden] amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamid, (3.022) (2E,3Z)-5-{[1-(4-Chlorphenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamid, (3.023) (2R)-2-{2-[(2,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamid, (3.024) (2S)-2-{2-[(2,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamid, (3.025) (3S,6S,7R,8R)-8-Benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl-2-methylpropanoat, (3.026) 2-{2-[(2,5-Dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamid, (3.027) N-(3-Ethyl-3,5,5-trimethylcyclohexyl)-3-formamido-2-hydroxybenzamid, (3.028) (2E,3Z)-5-{[1-(4-Chlor-2-fluorphenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamid, (3.029) Methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl] -2-methylbenzyl} carbamate. 4) Inhibitoren der Mitose und Zellteilung, beispielsweise (4.001) Carbendazim, (4.002) Diethofencarb, (4.003) Ethaboxam, (4.004) Fluopicolid, (4.005) Pencycuron, (4.006) Thiabendazol, (4.007) Thiophanat-Methyl, (4.008) Zoxamid, (4.009) 3-Chlor-4-(2,6-difluorphenyl)-6-methyl-5-phenylpyridazin, (4.010) 3-Chlor-5-(4-chlorphenyl)-4-(2,6-difluorphenyl)-6-methylpyridazin, (4.011) 3-Chlor-5-(6-chlorpyridin-3-yl)-6-methyl-4-(2,4,6-trifluorphenyl)pyridazin, (4.012) 4-(2-Brom-4-fluorphenyl)-N-(2,6-difluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.013) 4-(2-Brom-4-fluorphenyl)-N-(2-brom-6-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.014) 4-(2-Brom-4-fluorphenyl)-N-(2-bromphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.015) 4-(2-Brom-4-fluorphenyl)-N-(2-chlor-6-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.016) 4-(2-Brom-4-fluorphenyl)-N-(2-chlorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.017) 4-(2-Brom-4-fluorphenyl)-N-(2-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.018) 4-(2-Chlor-4-fluorphenyl)-N-(2,6-difluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.019) 4-(2-Chlor-4-fluorphenyl)-N-(2-chlor-6-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.020) 4-(2-Chlor-4-fluorphenyl)-N-(2-chlorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.021) 4-(2-Chlor-4-fluorphenyl)-N-(2-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.022) 4-(4-Chlorphenyl)-5-(2,6-difluorphenyl)-3,6-dimethylpyridazin, (4.023) N-(2-Brom-6-fluorphenyl)-4-(2-chlor-4-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.024) N-(2-Bromphenyl)-4-(2-chlor-4-fluorphenyl)-1,3-dimethyl-1H-pyrazol-5-amin, (4.025) N-(4-Chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine. 5) Compounds capable of multisite activity, for example (5.001) Bordeaux mixture, (5.002) Captafol, (5.003) Captan, (5.004) Chlorothalonil, (5.005) Copper hydroxide, (5.006) Copper naphthenate, (5.007) Copper oxide, (5.008) Copper oxychloride, (5.009) Copper(2+) sulfate, (5.010) Dithianon, (5.011) Dodine, (5.012) Folpet, (5.013) Mancozeb, (5.014) Maneb, (5.015) Metiram, (5.016) Zinc metiram, (5.017) Copper oxine, (5.018) Propineb, (5.019) Sulfur and sulfur preparations including calcium polysulfide, (5.020) Thiram, (5.021) Zineb, (5.022) Ziram, (5.023) 6-Ethyl-5,7-dioxo-6,7-dihydro-5H-pyrrolo[3',4':5,6][1,4]dithiino[2,3-c][1,2]thiazole-3-carbonitrile. 6) Compounds capable of triggering host defense, for example (6.001) Acibenzolar-S-Methyl, (6.002) Isotianil, (6.003) Probenazole, (6.004) Tiadinil.7) Inhibitors of amino acid and / or protein biosynthesis, for example (7.001) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracycline, (7.005) pyrimethanil, (7.006) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinoline-1-yl)quinoline. (8) Inhibitors of ATP production, for example (8.001) silthiofam. 9) Inhibitors of cell wall synthesis, for example (9.001) Benthiavalicarb, (9.002) Dimethomorph, (9.003) Flumorph, (9.004) Iprovalicarb, (9.005) Mandipropamid, (9.006) Pyrimorph, (9.007) Valifenalate, (9.008) (2E)-3-(4-tert-Butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (9.009) (2Z)-3-(4-tert-Butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one. 10) Inhibitors of lipid and membrane synthesis, for example (10.001) propamocarb, (10.002) propamocarb hydrochloride, (10.003) tolclofos methyl. 11) Inhibitors of melanin biosynthesis, for example (11.001) tricyclazole, (11.002) 2,2,2-Trifluoroethyl-{3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl} carbamate. 12) Nucleic acid synthesis inhibitors, for example (12.001) Benalaxyl, (12.002) Benalaxyl-M (Kiralaxyl), (12.003) Metalaxyl, (12.004) Metalaxyl-M (Mefenoxam). 13) Signal transduction inhibitors, for example (13.001) Fludioxonil, (13.002) Iprodione, (13.003) Procymidone, (13.004) Proquinazide, (13.005) Quinoxyfen, (13.006) Vinclozoline. 14) Compounds that can act as uncouplers, for example (14.001) Fluazinam, (14.002) Meptyldinocap. 15) Other compounds, for example (15.001) abscisic acid, (15.002) benthiazole, (15.003) bethoxazine, (15.004) capsimycin, (15.005) carvone, (15.006) quinomethionate, (15.007) cufraneb, (15.008) cyflufenamide, (15.009) cymoxanil, (15.010) cyprosulfamide, (15.011) flutianil, (15.012) fosetyl aluminum, (15.013) fosetyl calcium, (15.014) fosetyl sodium, (15.015) methyl isothiocyanate, (15.016) metrafenone, (15.017) mildiomycin, (15.018) Natamycin, (15.019) Nickel-Dimethyldithiocarbamat, (15.020) Nitrothal-Isopropyl, (15.021) Oxamocarb, (15.022) Oxathiapiprolin, (15.023) Oxyfenthiin, (15.024) Pentachlorphenol und Salze, (15.025) Phosphonsäure und deren Salze, (15.026) Propamocarb-fosetylat, (15.027) Pyriofenone (Chlazafenone) (15.028) Tebufloquin, (15.029) Tecloftalam, (15.030) Tolnifanide, (15.031) 1-(4-{ 4-[(5R)-5-(2,6-Difluorphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1 -yl)-2-[5-methyl-3-(trifluormethyl)- 1H-pyrazol-1 -yl]ethanon, (15.032) 1-(4-{4-[(SS)-5-(2,6-Difluorphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluormethyl)-1H-pyrazol-1-yl]ethanon, (15.033) 2-(6-Benzylpyridin-2-yl)quinazolin, (15.034) 2,6-Dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c']dipyrrol-1,3,5,7(2H,6H)-tetron, (15.035) 2-[3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-in-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanon, (15.036) 2-[3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chlor-6-(prop-2-in-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanon, (15.037) 2-[3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluor-6-(prop-2-in-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanon, (15.038) 2-[6-(3-Fluor-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazolin, (15.039) 2-{(SR)-3-[2-(1-{ [3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorphenyl methanesulfonat, (15.040) 2-{(5S)-3-[2-(1-{[3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorphenyl methanesulfonat, (15.041) 2-{2-[(7,8-Difluor-2-methylquinolin-3-yl)oxy]-6-fluorphenyl}propan-2-ol, (15.042) 2-{2-Fluor-6-[(8-fluor-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol, (15.043) 2-{3-[2-(1-{[3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorphenyl-methansulfonat, (15.044) 2-{3-[2-(1-{[3,5-Bis(difluormethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonat, (15.045) 2-Phenylphenol und deren Salze, (15.046) 3-(4,4,5-Trifluor-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinolin, (15.047) 3-(4,4-Difluor-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinolin, (15.048) 4-Amino-5-fluorpyrimidin-2-ol (Tautomere Form: 4-Amino-5-fluorpyrimidin-2(1H)-on), (15.049) 4-Oxo-4-[(2-phenylethyl)amino]buttersäure, (15.050) 5-Amino-1,3,4-thiadiazol-2-thiol, (15.051) 5-Chlor-N'-phenyl-N'-(prop-2-yn-1-yl)thiophen-2-sulfonohydrazid, (15.052) 5-Fluor-2-[(4-fluorbenzyl)oxy]pyrimidin-4-amin, (15.053) 5-Fluor-2-[(4-methylbenzyl)oxy]pyrimidin-4-amin, (15.054) 9-Fluor-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxazepin, (15.055) But-3-yn-1-yl {6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylen]amino}oxy)methyl]pyridin-2-yl}carbamat, (15.056) Ethyl (2Z)-3-amino-2-cyano-3-phenylacrylat, (15.057) Phenazin-1-carbonsäure, (15.058) Propyl 3,4,5-trihydroxybenzoat, (15.059) Quinolin-8-ol, (15.060) Quinolin-8-ol sulfat (2:1), (15.061) tert-Butyl {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene] amino}oxy)methyl]pyridin-2-yl} carbamat, (15.062) 5-Fluor-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one.Insektizide Wirkstoffe sind beispielsweise : (1) Acetylcholinesterase (AChE) Inhibitoren, wie beispielsweise Carbamate, z.B. Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarboxim, Butoxycarboxim, Carbaryl, Carbofuran, Carbosulfan, Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, Pirimicarb, Propoxur, Thiodicarb, Thiofanox, Triazamate, Trimethacarb, XMC und Xylylcarb oder organophosphate, z.B.Acephate, Azamethiphos, Azinphos-ethyl, Azinphos-methyl, Cadusafos, Chlorethoxyfos, Chlorfenvinphos, Chlormephos, Chlorpyrifos, Chlorpyrifos-methyl, Coumaphos, Cyanophos, Demeton-S-methyl, Diazinon, Dichlorvos / DDVP, Dicrotophos, Dimethoate, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fosthiazate, Heptenophos, Imicyafos, Isofenphos, Isopropyl O-(methoxyaminothio-phosphoryl) salicylat, Isoxathion, Malathion, Mecarbam, Methamidophos, Methidathion, Mevinphos, Monocrotophos, Naled, Omethoate, Oxydemeton-methyl, Parathion, Parathion-methyl, Phenthoate, Phorate, Phosalone, Phosmet, Phosphamidon, Phoxim, Pirimiphos-methyl, Profenofos, Propetamphos, Prothiofos, Pyraclofos, Pyridaphenthion, Quinalphos, Sulfotep, Tebupirimfos, Temephos, Terbufos, Tetrachlorvinphos, Thiometon, Triazophos, Triclorfon und Vamidothion. (2) GABA-gesteuerte Chlorid-Kanal-Antagonisten, wie beispielsweise Cyclodien-organochlorine, z.B.Chlordanes and endosulfan or phenylpyrazoles (fiprols), e.g. ethiprol and fipronil. (3) Sodium channel modulators / voltage-dependent sodium channel blockers, such as pyrethroids, e.g. acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(1R)-trans isomers], deltamethrin, empenthrin [(EZ)-(1R) isomers), esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-Fluvalinate, Halfenprox, Imiprothrin, Kadethrin, Momfluorothrin, Permethrin, Phenothrin [(1R)-trans-Isomer), Prallethrin, Pyrethrins (pyrethrum), Resmethrin, Silafluofen, Tefluthrin, Tetramethrin, Tetramethrin [(1R)-Isomers)], Tralomethrin and Transfluthrin or DDT or Methoxychlor.(4) Nicotinic acetylcholine receptor (nAChR) agonists, such as neonicotinoids, e.g., acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, and thiamethoxam, or nicotine, or sulfoxaflor, or flupyradifurone. (5) Nicotinic acetylcholine receptor (nAChR) allosteric activators, such as spinosins, e.g., spinetoram and spinosad. (6) Chloride channel activators, such as avermectins / milbemycins, e.g., abamectin, emamectin benzoate, lepimectin, and milbemectin. (7) Juvenile hormone mimics, such as juvenile hormone analogs, e.g., hydroprene, kinoprene, and methoprene, or fenoxycarb or pyriproxyfen. (8) Active substances with unknown or non-specific mechanisms of action, such as alkyl halides, e.g., methyl bromide and other alkyl halides; or chloropicrin or sulfuryl fluoride or borax or tartar emetic. (9) Selective feeding deterrents, e.g., pymetrozine or flonicamide. (10) Mite growth inhibitors, e.g.Clofentezine, hexythiazox and diflovidazine or etoxazoles. (11) Microbial disruptors of the insect intestinal membrane, e.g. Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis and BT plant proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34 / 35Ab1. (12) Inhibitors of oxidative phosphorylation, ATP disruptors, such as diafenthiuron or organotin compounds, e.g. azocyclotin, cyhexatine and fenbutatin oxide or propargite or tetradifone. (13) Uncouplers of oxidative phosphorylation by interrupting the H-proton gradient, such as chlorfenapyr, DNOC, and sulfuramide. (14) Nicotinic acetylcholine receptor antagonists, such as Bensultap, Cartap hydrochloride, thiocyclam, and thiosultap sodium.(15) Type 0 chitin biosynthesis inhibitors, such as bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumurone, lufenuron, novaluron, noviflumurone, teflubenzuron, and triflumurone. (16) Type 1 chitin biosynthesis inhibitors, such as buprofezin. (17) Molting inhibitors, dipterans, such as cyromazine. (18) Ecdysone receptor agonists, such as chromafenozides, halofenozides, methoxyfenozides, and tebufenozides. (19) Octomatergic agonists, such as amitraz. (20) Complex III electron transport inhibitors, such as hydramethylnone, acequinocyl, or fluacrypyrim. (21) Complex I electron transport inhibitors, for example METI acaricides, e.g. fenazaquin, fenpyroximates, pyrimidifen, pyridaben, tebufenpyrad and tolfenpyrad or rotenones (Derris). (22) Voltage-gated sodium channel blockers, e.g. indoxacarb or metaflumizone.(23) Acetyl-CoA carboxylase inhibitors, such as tetronic and tetramic acid derivatives, e.g., spirobudiclofen, spirodiclofen, spiromesifen, and spirotetramate. (24) Complex IV electron transport inhibitors, such as phosphines, e.g., aluminum phosphide, calcium phosphide, phosphine, and zinc phosphide, or cyanide. (25) Complex II electron transport inhibitors, such as cyenopyrafen and cyflumetofen. (28) Ryanodine receptor effectors, such as diamides, e.g., chloroantraniliproles, cyantraniliproles, flubendiamides, and tetrachloroantraniliproles.

[0055] Other insecticidal active ingredients with unknown or unclear mechanisms of action, such as afidopyropene, afoxolaner, azadirachtin, benclothiaz, benzoximates, bifenazates, broflanilides, bromopropylates, quinomethionate, cryolite, cyclaniliproles, cycloxaprid, cyhalodiamides, dicloromezotiaz, dicofol, diflovidazine, flometoquine, fluazaindolizine, fluensulfone, flufenerim, flufenoxystrobin, flufiproles, fluhexafone, fluopyram, fluralaner, fluxametamide, fufenozide, guadipyr, heptafluthrin, imidaclothiz, iprodione, lotilaner, meperfluthrin, paichongding, pyflubumide, pyridalyl, pyrifluquinazone, pyriminostrobin, sarolaner, and tetramethylfluthrin. Tetraniliprole, tetrachloroantraniliprole, tioxazafen, thiofluoximate, triflumezopyrim and iodomethane; furthermore, preparations based on Bacillus firmus (I-1582, BioNeem, Votivo), as well as the following known active compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine (known from WO2006 / 043635), {1'-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indol-3,4'-piperidine]-1(2H)-yl}(2-chloropyridin-4-yl)methanone (known from WO2003 / 106457), 2-chloro-N-[2-{1-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]piperidin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO2006 / 003494), 3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one (known from WO2009 / 049851), 3-(2,5-Dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-yl-ethylcarbonate (known from WO2009 / 049851), 4-(But-2-yne-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine (known from WO2004 / 099160), 4-(But-2-yne-1-yloxy)-6-(3-chlorophenyl)pyrimidine (known from WO2003 / 076415), PF1364 (CAS Reg. No. 1204776-60-2), Methyl 2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro-3-methylbenzoyl]-2-methylhydrazine carboxylate (known from WO2005 / 085216),Methyl-2-[2-({[3-brom-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyan-3-methylbenzoyl]-2-ethylhydrazincarboxylat (bekannt aus WO2005 / 085216), Methyl-2-[2-({[3-brom-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl} amino)-5-cyan-3-methylbenzoyl]-2-methylhydrazincarboxylat (bekannt aus WO2005 / 085216), Methyl-2-[3,5-dibrom-2-({[3-brom-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethylhydrazincarboxylat (bekannt aus WO2005 / 085216), N-[2-(5-Amino-1,3,4-thiadiazol-2-yl)-4-chlor-6-methylphenyl]-3-brom-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-carboxamid (bekannt aus CN102057925), 4-[5-(3,5-Dichlorphenyl)-5-(trifluormethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-(1-oxidothietan-3-yl)benzamid (bekannt aus WO2009 / 080250), N-[(2E)-1-[(6-Chlorpyridin-3-yl)methyl]pyridin-2(1H)-yliden]-2,2,2-trifluoracetamid (bekannt aus WO2012 / 029672), 1-[(2-Chlor-1,3-thiazol-5-yl)methyl]-4-oxo-3-phenyl-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olat (bekannt aus WO2009 / 099929),1-[(6-Chlorpyridin-3-yl)methyl]-4-oxo-3-phenyl-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olat (bekannt aus WO2009 / 099929), 4-(3-{2,6-Dichlor-4-[(3,3-dichlorprop-2-en-1-yl)oxy]phenoxy}propoxy)-2-methoxy-6-(trifluormethyl)pyrimidin (bekannt aus CN101337940), N-[2-(tert-Butylcarbamoyl)-4-chlor-6-methylphenyl]-1-(3-chlorpyridin-2-yl)-3-(fluormethoxy)-1H-pyrazol-5-carboxamid (bekannt aus WO2008 / 134969), Butyl-[2-(2,4-dichlorphenyl)-3-oxo-4-oxaspiro[4.5]dec-1-en-1-yl]-carbonat (bekannt aus CN 102060818), (3E)-3-[1-[(6-Chlor-3-pyridyl)methyl]-2-pyridyliden]-1,1,1-trifluor-propan-2-on (bekannt aus WO2013 / 144213), N-(Methylsulfonyl)-6-[2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-carboxamid (bekannt aus WO2012 / 000896), N-[3-(Benzylcarbamoyl)-4-chlorphenyl]-1-methyl-3-(pentafluorethyl)-4-(trifluormethyl)-1H-pyrazol-5-carboxamid (bekannt aus WO2010 / 051926), 5-Brom-4-chlor-N-[4-chlor-2-methyl-6-(methylcarbamoyl)phenyl] -2-(3-chlor-2-pyridyl)pyrazole-3-carboxamid (bekannt aus CN103232431), Tioxazafen,4-[5-(3,5-Dichlorphenyl)-4,5-dihydro-5-(trifluormethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxido-3-thietanyl)-benzamid, 4-[5-(3,5-Dichlorphenyl)-4,5-dihydro-5-(trifluormethyl)-3-isoxazolyl]-2-methyl-N-(trans-1-oxido-3-thietanyl)-benzamid und 4-[(5S)-5-(3,5-Dichlorphenyl)-4,5-dihydro-5-(trifluormethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-oxido-3-thietanyl)benzamid (bekannt aus WO 2013050317 A1), N-[3-Chlor-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluorpropyl)sulfinyl]-propanamid, (+)-N-[3-Chlor-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluorpropyl)sulfinyl]-propanamid und (-)-N-[3-Chlor-1-(3-pyridinyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluorpropyl)sulfinyl]-propanamid (bekannt aus WO 2013162715 A2, WO 2013162716 A2, US 20140213448 A1), 5-[[(2E)-3-Chlor-2-propen-1-yl]amino]-1-[2,6-dichlor-4-(trifluoromethyl)phenyl]-4-[(trifluormethyl)sulfinyl]-1H-pyrazol-3-carbonitril (bekannt aus CN 101337937 A),3-Brom-N-[4-chlor-2-methyl-6-[(methylamino)thioxomethyl]phenyl]-1-(3-chlor-2-pyridinyl)-1H-pyrazol-5-carboxamid, (Liudaibenjiaxuanan, bekannt aus CN 103109816 A); N-[4-Chlor-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chlor-2-pyridinyl)-3-(fluormethoxy)-1H-pyrazol-5-carboxamid (bekannt aus WO 2012034403 A1), N-[2-(5-Amino-1,3,4-thiadiazol-2-yl)-4-chlor-6-methylphenyl]-3-brom-1-(3-chlor-2-pyridinyl)-1H-pyrazol-5-carboxamid (bekannt aus WO 2011085575 A1), 4-[3-[2,6-Dichlor-4-[(3,3-dichlor-2-propen-1-yl)oxy]phenoxy]propoxy]-2-methoxy-6-(trifluormethyl)-pyrimidin (bekannt aus CN 101337940 A); (2E)- und (2Z)-2-[2-(4-Cyanophenyl)-1-[3-(trifluormethyl)phenyl] ethylidene] -N- [4-(difluormethoxy)phenyl] -hydrazine-carboxamid (bekannt aus CN 101715774 A); 3-(2,2-Dichloroethenyl)-2,2-dimethyl-4-(1H-benzimidazol-2-yl)phenyl-cyclopropan-carbonsäureester (bekannt aus CN 103524422 A); (4aS)-7-Chlor-2,5-dihydro-2-[[(methoxycarbonyl)[4-[(trifluoromethyl)thio]phenyl]amino]carbonyl]-indeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylic acid methyl ester (known from CN 102391261 A)., Examples of herbicidal mixing partners are:

[0056] Acetochlor, acifluorfen, acifluorfen-sodium, aclonifen, alachlor, allidochlor, alloxydim, alloxydimsodium, ametryn, amicarbazone, amidochlor, amidosulfuron, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methylphenyl)-5-fluoropyridine-2-carboxylic acid, aminocyclopyrachlor, aminocyclopyrachlorpotassium, aminocyclopyrachlor-methyl, aminopyralid, amitrole, ammoniumsulfamate, anilofos, asulam, atrazine, azafenidin, azimsulfuron, beflubutamid, benazolin, benazolin-ethyl, benfluralin, benfuresate, bensulfuron, bensulfuron-methyl, bensulide, bentazone, benzobicyclon, benzofenap, bicyclopyron, bifenox, bilanafos, bilanafos-sodium, bispyribac, bispyribac-sodium, bromacil, bromobutide, bromofenoxim, bromoxynil, bromoxynil-butyrate, -potassium, -heptanoate und -octanoate, busoxinone, butachlor, butafenacil, butamifos, butenachlor, butralin, butroxydim, butylate, cafenstrole, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chlorbromuron, chlorfenac, chlorfenac-sodium, chlorfenprop,chlorflurenol, chlorflurenol-methyl, chloridazon, chlorimuron, chlorimuron-ethyl, chlorophthalim, chlorotoluron, chlorthal-dimethyl, chlorsulfuron, cinidon, cinidon-ethyl, cinmethylin, cinosulfuron, clacyfos, clethodim, clodinafop, clodinafop-propargyl, clomazone, clomeprop, clopyralid, cloransulam, cloransulam-methyl, cumyluron, cyanamide, cyanazine, cycloate, cyclopyrimorate, cyclosulfamuron, cycloxydim, cyhalofop, cyhalofop-butyl, cyprazine, 2,4-D, 2,4-D-butotyl, -butyl, - dimethylammonium, -diolamin, -ethyl, 2-ethylhexyl, -isobutyl, -isooctyl, -isopropylammonium, - potassium, -triisopropanolammonium und -trolamine, 2,4-DB, 2,4-DB-butyl, -dimethylammonium, isooctyl, -potassium und -sodium, daimuron (dymron), dalapon, dazomet, n-decanol, desmedipham, detosyl-pyrazolate (DTP), dicamba, dichlobenil, 2-(2,4-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, 2-(2,5-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, dichlorprop, dichlorprop-P, diclofop, diclofop-methyl, diclofop-P-methyl,diclosulam, difenzoquat, diflufenican, diflufenzopyr, diflufenzopyrsodium, dimefuron, dimepiperate, dimethachlor, dimethametryn, dimethenamid, dimethenamid-P, dimetrasulfuron, dinitramine, dinoterb, diphenamid, diquat, diquat-dibromid, dithiopyr, diuron, DNOC, endothal, EPTC, esprocarb, ethalfluralin, ethametsulfuron, ethametsulfuron-methyl, ethiozin, ethofumesate, ethoxyfen, ethoxyfen-ethyl, ethoxysulfuron, etobenzanid, F-9600, F-5231, i.e. N-[2-Chlor-4-fluor-5-[4-(3-fluorpropyl)-4,5-dihydro-5-oxo-1H-tetrazol-1-yl]-phenyl]-ethansulfonamid, F-7967, i.e. 3-[7-Chlor-5-fluor-2-(trifluormethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluormethyl)pyrimidin-2,4(1H,3H)-dion, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop-P-ethyl, fenoxasulfone, fenquinotrione, fentrazamide, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, florasulam, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, flucarbazone, flucarbazone-sodium, flucetosulfuron, fluchloralin, flufenacet,flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumioxazin, fluometuron, flurenol, flurenol-butyl, -dimethylammonium und -methyl, fluoroglycofen, fluoroglycofen-ethyl, flupropanate, flupyrsulfuron, flupyrsulfuron-methyl-sodium, fluridone, flurochloridone, fluroxypyr, fluroxypyr-meptyl, flurtamone, fluthiacet, fluthiacet-methyl, fomesafen, fomesafen-sodium, foramsulfuron, fosamine, glufosinate, glufosinate-ammonium, glufosinate-P-sodium, glufosinate-P-ammonium, glufosinate-P-sodium, glyphosate, glyphosateammonium, -isopropylammonium, -diammonium, -dimethylammonium, -potassium, -sodium und - trimesium, H-9201, i.e. O-(2,4-Dimethyl-6-nitrophenyl)-O-ethyl-isopropylphosphoramidothioat, halauxifen, halauxifen-methyl, halosafen, halosulfuron, halosulfuron-methyl, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, hexazinone, HW-02, i.e. 1-(Dimethoxyphosphoryl)-ethyl-(2,4-dichlorphenoxy)acetat,imazamethabenz, Imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquin-ammonium, imazethapyr, imazethapyrimmonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron-methyl-sodium, ioxynil, ioxynil-octanoate, -potassium und sodium, ipfencarbazone, isoproturon, isouron, isoxaben, isoxaflutole, karbutilate, KUH-043, i.e. 3-({ [5-(Difluormethyl)-1-methyl-3-(trifluormethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazol, ketospiradox, lactofen, lenacil, linuron, MCPA, MCPA-butotyl, -dimethylammonium, -2-ethylhexyl, -isopropylammonium, -potassium und - sodium, MCPB, MCPB-methyl, -ethyl und -sodium, mecoprop, mecoprop-sodium, und -butotyl, mecoprop-P, mecoprop-P-butotyl, -dimethylammonium, -2-ethylhexyl und -potassium, mefenacet, mefluidide, mesosulfuron, mesosulfuron-methyl, mesotrione, methabenzthiazuron, metam, metamifop, metamitron, metazachlor, metazosulfuron,methabenzthiazuron, methiopyrsulfuron, methiozolin, methyl isothiocyanate, metobromuron, metolachlor, S-metolachlor, metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinat, monolinuron, monosulfuron, monosulfuron-ester, MT-5950, i.e. N-[3-chlor-4-(1-methylethyl)-phenyl]-2-methylpentanamid, NGGC-011, napropamide, NC-310, i.e. 4-(2,4-Dichlorbenzoyl)-1-methyl-5-benzyloxypyrazol, neburon, nicosulfuron, nonanoic acid (Pelargonsäure), norflurazon, oleic acid (fatty acids), orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxasulfuron, oxaziclomefon, oxyfluorfen, paraquat, paraquat dichloride, pebulate, pendimethalin, penoxsulam, pentachlorphenol, pentoxazone, pethoxamid, petroleum oils, phenmedipham, picloram, picolinafen, pinoxaden, piperophos, pretilachlor, primisulfuron, primisulfuron-methyl, prodiamine, profoxydim, prometon, prometryn, propachlor, propanil, propaquizafop, propazine, propham, propisochlor, propoxycarbazone, propoxycarbazone-sodium,propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen, pyraflufen-ethyl, pyrasulfotole, pyrazolynate (pyrazolate), pyrazosulfuron, pyrazosulfuron-ethyl, pyrazoxyfen, pyribambenz, pyribambenz-isopropyl, pyribambenz-propyl, pyribenzoxim, pyributicarb, pyridafol, pyridate, pyriftalid, pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyrithiobac-sodium, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quinoclamine, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, rimsulfuron, saflufenacil, sethoxydim, siduron, simazine, simetryn, SL-261, sulcotrion, sulfentrazone, sulfometuron, sulfometuron-methyl, sulfosulfuron, SYN-523, SYP-249, i.e. 1-Ethoxy-3-methyl-1-oxobut-3-en-2-yl-5-[2-chlor-4-(trifluormethyl)phenoxy]-2-nitrobenzoat, SYP-300, i.e. 1-[7-Fluor-3-oxo-4-(prop-2-in-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioxoimidazolidin-4,5-dion, 2,3,6-TBA, TCA (Trifluoressigsäure), TCA-sodium, tebuthiuron,tefuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbumetone, terbuthylazine, terbutryn, thenylchlor, thiazopyr, thiencarbazone, thiencarbazone-methyl, thifensulfuron, thifensulfuron-methyl, thiobencarb, tiafenacil, tolpyralate, topramezone, tralkoxydim, triafamone, tri-allate, triasulfuron, triaziflam, tribenuron, tribenuron-methyl, triclopyr, trietazine, trifloxysulfuron, trifloxysulfuron-sodium, trifludimoxazine, trifluralin, triflusulfuron, triflusulfuron-methyl, tritosulfuron, urea sulfate, vernolate, XDE-848, ZJ-0862, ie 3,4-Dichloro-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}aniline, and the following compounds: , Examples of plant growth regulators as possible mixing partners are:

[0057] Acibenzolar, acibenzolar-S-methyl, 5-Aminolävulinsäure, ancymidol, 6-benzylaminopurine, Brassinolid, Catechin, chlormequat chloride, cloprop, cyclanilide, 3-(Cycloprop-1-enyl)propionsäure, daminozide, dazomet, n-decanol, dikegulac, dikegulac-sodium, endothal, endothal-dipotassium, -disodium, und mono(N,N-dimethylalkylammonium), ethephon, flumetralin, flurenol, flurenol-butyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfide, indol-3-acetic acid (IAA), 4-indol-3-ylbutyric acid, isoprothiolane, probenazole, Jasmonsäure, Jasmonsäuremethylester, maleic hydrazide, mepiquat chloride, 1-methylcyclopropene, 2-(1-naphthyl)acetamide, 1-naphthylacetic acid, 2- naphthyloxyacetic acid, nitrophenolate-mixture, 4-Oxo-4[(2-phenylethyl)amino]buttersäure, paclobutrazol, N-phenylphthalamic acid, prohexadione, prohexadione-calcium, prohydrojasmone, Salicylsäure, Strigolacton, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tsitodef, uniconazole, uniconazole-P.

[0058] The following groups of compounds, for example, are potential safeners: S1) Compounds from the group of heterocyclic carboxylic acid derivatives: S1 a< ) Compounds of the dichlorophenylpyrazolin-3-carboxylic acid type (S1 a< ), preferably compounds such as 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazolin-3-carboxylic acid, 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazolin-3-carboxylic acid ethyl ester (S1-1) (“Mefenpyr-diethyl”), and related compounds as described in WO-A-91 / 07874; S1 b< ) Derivatives of dichlorophenylpyrazole carboxylic acid (S1 b< ), preferably compounds such as 1-(2,4-dichlorophenyl)-5-methylpyrazole-3-carboxylic acid ethyl ester (S1-2), 1-(2,4-dichlorophenyl)-5-isopropylpyrazole-3-carboxylic acid ethyl ester (S1-3), 1-(2,4-dichlorophenyl)-5-(1,1-dimethyl-ethyl)pyrazole-3-carboxylic acid ethyl ester (S1-4) and related compounds as described in EP-A-333 131 and EP-A-269 806; S1 c< ) Derivatives of 1,5-diphenylpyrazole-3-carboxylic acid (S1 c< ), preferably compounds such as 1-(2,4-Dichlorophenyl)-5-phenylpyrazole-3-carboxylic acid ethyl ester (S1-5), 1-(2-chlorophenyl)-5-phenylpyrazole-3-carboxylic acid methyl ester (S1-6) and related compounds as described, for example, in EP-A-268554; S1 d< ) compounds of the triazole carboxylic acid type (S1 d< ), preferably compounds such as fenchlorazole(-ethyl ester), i.e. 1-(2,4-dichlorophenyl)-5-trichloromethyl-(1H)-1,2,4-triazole-3-carboxylic acid ethyl ester (S1-7), and related compounds as described in EP-A-174 562 and EP-A-346 620; S1 e< ) Compounds of the type of 5-benzyl or 5-phenyl-2-isoxazoline-3-carboxylic acid, or of 5,5-diphenyl-2-isoxazoline-3-carboxylic acid (S1 e< ), preferably compounds such as 5-(2,4-dichlorobenzyl)-2-isoxazoline-3-carboxylic acid ethyl ester (S1-8) or 5-phenyl-2-isoxazoline-3-carboxylic acid ethyl ester (S1-9) and related compounds as described in WO-A-91 / 08202, or 5,5-diphenyl-2-isoxazoline-carboxylic acid (S1-10) or 5,5-Diphenyl-2-isoxazoline-3-carboxylic acid ethyl ester (S1-11) ("Isoxadifen-ethyl") or -n-propyl ester (S1-12) or 5-(4-Fluorphenyl)-5-phenyl-2-isoxazoline-3-carboxylic acid ethyl ester (S1-13), as described in patent application WO-A-95 / 07897. S2) Compounds from the group of 8-quinoline oxide derivatives (S2): S2 a< ) Compounds of the type of 8-quinoline oxyacetic acid (S2 a< ), preferably (5-chloro-8-quinoline oxy)acetic acid (1-methylhexyl) ester ("cloquintocet-mexyl") (S2-1), (5-chloro-8-quinoline oxy)acetic acid (1,3-dimethyl-but-1-yl) ester (S2-2), (5-chloro-8-quinoline oxy)acetic acid 4-allyl-oxy-butyl ester (S2-3), (5-chloro-8-quinoline oxy)acetic acid 1-allyloxy-prop-2-yl ester (S2-4), (5-chloro-8-quinoline oxy)acetic acid ethyl ester (S2-5), (5-chloro-8-quinoline oxy)acetic acid methyl ester (S2-6), (5-Chloro-8-quinolineoxy)acetic acid allyl ester (S2-7), (5-Chloro-8-quinolineoxy)acetic acid 2-(2-propylidene-iminoxy)-1-ethyl ester (S2-8),(5-Chloro-8-quinolineoxy)acetic acid 2-oxo-prop-1-yl ester (S2-9) and related compounds as described in EP-A-86 750, EP-A-94 349 and EP-A-191 736 or EP-A-0 492 366, as well as (5-chloro-8-quinolineoxy)acetic acid (S2-10), its hydrates and salts, for example its lithium, sodium, potassium, calcium, magnesium, aluminium, iron, ammonium, quaternary ammonium, sulfonium or phosphonium salts as described in WO-A-2002 / 34048; S2 b< ) Compounds of the type of (5-chloro-8-quinolineoxy)malonic acid (S2 b< ), preferably compounds such as (5-chloro-8-quinolineoxy)malonic acid diethyl ester, (5-chloro-8-quinolineoxy)malonic acid diallyl ester, (5-chloro-8-quinolineoxy)malonic acid methyl ethyl ester and related compounds as described in EP-A-0 582 198. S3) Active ingredients of the type of dichloroacetamides (S3) commonly used as pre-emergence safeners (soil-active safeners), such as "Dichlormide" (N,N-diallyl-2,2-dichloroacetamide) (S3-1),"R-29148" (3-Dichloracetyl-2,2,5-trimethyl-1,3-oxazolidin) der Firma Stauffer (S3-2), "R-28725" (3-Dichloracetyl-2,2,-dimethyl-1,3-oxazolidin) der Firma Stauffer (S3-3), "Benoxacor" (4-Dichloracetyl-3,4-dihydro-3-methyl-2H-1,4-benzoxazin) (S3-4), "PPG-1292" (N-Allyl-N-[(1,3-dioxolan-2-yl)-methyl]-dichloracetamid) der Firma PPG Industries (S3-5), "DKA-24" (N-Allyl-N-[(allylaminocarbonyl)methyl]-dichloracetamid) der Firma Sagro-Chem (S3-6), "AD-67" oder "MON 4660" (3-Dichloracetyl-1-oxa-3-aza-spiro[4,5]decan) der Firma Nitrokemia bzw. Monsanto (S3-7), "TI-35" (1-Dichloracetyl-azepan) der Firma TRI-Chemical RT (S3-8), "Diclonon" (Dicyclonon) oder "BAS145138" oder "LAB145138" (S3-9) ((RS)-1-Dichloracetyl-3,3,8a-trimethylperhydropyrrolo[1,2-a]pyrimidin-6-on) der Firma BASF, "Furilazol" oder "MON 13900" ((RS)-3-Dichloracetyl-5-(2-furyl)-2,2-dimethyloxazolidin) (S3-10),as well as its (R)-isomer (S3-11). S4) Compounds from the class of acylsulfonamides (S4): S4 a< ) N-acylsulfonamides of the formula (S4 a< ) and their salts as described in WO-A-97 / 45016, , wherein RA 1< (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, the latter two substituents being substituted by v A substituents from the group halogen, (C 1 -C 4 )alkoxy, (C 1 -C 6 )haloalkoxy and (C 1 -C 4 )alkylthio and, in the case of cyclic substituents, also by (C 1 -C 4 )alkyl and (C 1 -C 4 )haloalkyl; RA 2< halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, CF 3 ; m A 1 or 2; v A is 0, 1, 2 or 3; S4 b< ) Compounds of the type of 4-(benzoylsulfamoyl)benzamides of formula (S4 b< ) and their salts, as described in WO-A-99 / 16744, where RB1<, RB2< independently denote hydrogen, (C1-C6)alkyl, (C3-C6)cycloalkyl, (C3-C6)alkenyl, (C3-C6)alkynyl, RB3< halogen, (C1-C4)alkyl, (C1-C4)haloalkyl or (C1-C4)alkoxy and m B1 or 2, e.g., where RB1< = cyclopropyl, RB2< = hydrogen and (RB3<) = 2-OMe (“Cyprosulfamide”, S4-1), RB1< = cyclopropyl, RB2< = hydrogen and (RB3<) = 5-Cl-2-OMe (S4-2), RB1< = ethyl, RB2< = hydrogen and (RB3<) = 2-OMe is (S4-3), RB 1< = isopropyl, RB 2< = hydrogen and (RB 3< ) = 5-Cl-2-OMe is (S4-4) and RB 1< = isopropyl, RB 2< = hydrogen and (RB 3< ) = 2-OMe is (S4-5); S4 c< ) compounds from the class of benzoylsulfamoylphenylureas of the formula (S4 c< ), as described in EP-A-365484, where RC1< , RC2< independently denote hydrogen, (C1-C8)alkyl, (C3-C8)cycloalkyl, (C3-C6)alkenyl, (C3-C6)alkynyl, RC3< halogen, (C1-C4)alkyl, (C1-C4)alkoxy, CF3 and m represent C1 or C2; for example, 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3-methylurea, 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3,3-dimethylurea, 1-[4-(N-4,5-dimethylbenzoylsulfamoyl)phenyl]-3-methylurea; S4 d< ) Compounds of the type of N-phenylsulfonyl terephthalamides of the formula (S4 d< ) and their salts, which are known e.g. from CN 101838227, where RD 4< halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, CF 3 ; m D 1 or 2; RD 5< hydrogen, (C 1 -C 6 )alkyl, (C 3 -C 6 )cycloalkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, (C 5 -C 6 )cycloalkenyl. S5) Active substances from the class of hydroxyaromatics and aromatic-aliphatic carboxylic acid derivatives (S5), e.g. 3,4,5-triacetoxybenzoic acid ethyl ester, 3,5-dimethoxy-4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 4-hydroxysalicylic acid, 4-fluorosalicyclic acid, 2-hydroxycinnamic acid, 2,4-dichlorocinnamic acid, as described in WO-A-2004 / 084631, WO-A-2005 / 015994, WO-A-2005 / 016001. S6) Active substances from the class of 1,2-dihydroquinoxalin-2-ones (S6), e.g. 1-methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, 1-methyl-3-(2-thienyl)-1,2-dihydro-quinoxalin-2-thione, 1-(2-aminoethyl)-3-(2-thienyl)-1,2-dihydro-quinoxalin-2-one hydrochloride, 1-(2-methylsulfonylaminoethyl)-3-(2-thienyl)-1,2-dihydro-quinoxalin-2-one, as described in WO-A-2005 / 112630.S7) Compounds of the class of diphenylmethoxyacetic acid derivatives (S7), e.g., methyl diphenylmethoxyacetic acid ester (CAS Reg. No. 41858-19-9) (S7-1), ethyl diphenylmethoxyacetic acid ester, or diphenylmethoxyacetic acid as described in WO-A-98 / 38856. S8) Compounds of formula (S8) as described in WO-A-98 / 27049, wherein the symbols and indices have the following meanings: . RD 1< is halogen, (C 1 -C 4 )alkyl, (C 1 -C 4 )haloalkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkoxy, RD 2< is hydrogen or (C 1 -C 4 )alkyl, RD 3< is hydrogen, (C 1 -C 8 )alkyl, (C 2 -C 4 )alkenyl, (C 2 -C 4 )alkynyl, or aryl, wherein each of the aforementioned C-containing residues is unsubstituted or substituted by one or more, preferably up to three identical or different, residues from the group consisting of halogen and alkoxy; or their salts, n D is an integer from 0 to 2. S9) Active substances from the class of 3-(5-tetrazolylcarbonyl)-2-quinolones (S9), e.g. 1,2-Dihydro-4-hydroxy-1-ethyl-3-(5-tetrazolylcarbonyl)-2-quinolone (CAS Reg. No.: 219479-18-2), 1,2-Dihydro-4-hydroxy-1-methyl-3-(5-tetrazolyl-carbonyl)-2-quinolone (CAS Reg. No. 95855-00-8), as described in WO-A-1999 / 000020. S10) Compounds of the formulas (S10 a< ) or (S10 b< ) as described in WO-A-2007 / 023719 and WO-A-2007 / 023764, wherein RE 1< halogen, (C 1 - C 4 )alkyl, methoxy, nitro, cyano, CF 3 , OCF 3 YE , ZE independently of each other O or S, n E an integer from 0 to 4, RE 2< (C 1 - C 16 )alkyl, (C 2 - C 6 )alkenyl, (C 3 - C 6 )cycloalkyl, aryl; benzyl, halogenbenzyl, RE 3< hydrogen or (C 1 - C 6 )alkyl. S11) Active substances of the type of oxyimino compounds (S11) known as seed dressings, such as e.g. B. "Oxabetrinil" ((Z)-1,3-dioxolan-2-ylmethoxyimino(phenyl)acetonitrile) (S11-1), known as a seed treatment safener for millet against metolachlor damage, "Fluxofenim" (1-(4-chlorophenyl)-2,2,2-trifluoro-1-ethanone-O-(1,3-dioxolan-2-ylmethyl)-oxime) (S11-2), known as a seed treatment safener for millet against metolachlor damage, and "Cyometrinil" or "CGA-43089" ((Z)-cyanomethoxyimino(phenyl)acetonitrile) (S11-3), known as a seed treatment safener for millet against metolachlor damage. S12) Active substances from the class of isothiochromanones (S12), such asMethyl-[(3-oxo-1H-2-benzothiopyran-4(3H)-ylidene)methoxy]acetate (CAS Reg. No. 205121-04-6) (S12-1) and related compounds from WO-A-1998 / 13361. S13) One or more compounds from group (S13): "Naphthalic anhydride" (1,8-naphthalenedicarboxylic anhydride) (S13-1), known as a seed treatment safener for maize against damage from thiocarbama herbicides, "Fenclorim" (4,6-dichloro-2-phenylpyrimidine) (S13-2), known as a safener for pretilachlor in seeded rice, "Flurazole" (benzyl-2-chloro-4-trifluoromethyl-1,3-thiazol-5-carboxylate) (S13-3), known as a seed treatment safener for millet against damage from alachlor and metolachlor, "CL 304415" (CAS Reg. No. 31541-57-8) (4-carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic acid) (S13-4) of the company American Cyanamid, which is known as a safener for corn against damage from imidazolinones, "MG 191" (CAS Reg. No. 96420-72-3) (2-Dichloromethyl-2-methyl-1,3-dioxolane) (S13-5) of the company Nitrokemia, which is known as a safener for corn, "MG 838" (CAS Reg.No. 133993-74-5) (2-propenyl 1-oxa-4-azaspiro[4.5]decane-4-carbodithioate) (S13-6) of the company Nitrokemia "Disulfoton" (O,O-Diethyl S-2-ethylthioethyl phosphordithioate) (S13-7), "Dietholate" (O,O-Diethyl-O-phenylphosphorothioate) (S13-8), "Mephenate" (4-Chlorophenyl-methylcarbamate) (S13-9). S14) Active ingredients which, in addition to a herbicidal effect against weeds, also have a safener effect on cultivated plants such as rice, such as e.g."Dimepiperate" or "MY-93" (S-1-methyl-1-phenylethyl-piperidine-1-carbothioate), known as a rice safener against damage from the herbicide Molinate; "Daimuron" or "SK 23" (1-(1-methyl-1-phenylethyl)-3-p-tolyl-urea), known as a rice safener against damage from the herbicide Imazosulfuron; "Cumyluron" = "JC-940" (3-(2-chlorophenylmethyl)-1-(1-methyl-1-phenylethyl)urea, see JP-A-60087254), known as a rice safener against damage from some herbicides; "Methoxyphenone" or "NK 049" (3,3'-dimethyl-4-methoxybenzophenone), known as a rice safener against damage from some herbicides; "CSB" (1-Bromo-4-(chloromethylsulfonyl)benzene) from Kumiai, (CAS Reg. No. 54091-06-4), which is known as a safener against damage caused by some herbicides in rice. S15) Compounds of formula (S15) or their tautomers, as described in WO-A-2008 / 131861 and WO-A-2008 / 131860, . wherein RH1< denotes a (C1-C6)haloalkyl group and RH2< denotes hydrogen or halogen and RH3< , RH4< independently denote hydrogen, (C1-C16)alkyl, (C2-C16)alkenyl or (C2-C16)alkynyl, each of the latter 3 groups being unsubstituted or by one or more groups from the group consisting of halogen, hydroxy, cyano, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkylthio, (C1-C4)alkylamino, di[(C1-C4)alkyl]amino, [(C1-C4)alkoxy]carbonyl, [(C1-C4)haloalkoxy]carbonyl, (C3 (C6)Cycloalkyl, unsubstituted or substituted, phenyl, unsubstituted or substituted, and heterocyclyl, unsubstituted or substituted, or (C3-C6)cycloalkyl, (C4-C6)cycloalkenyl, (C3-C6)cycloalkyl fused to one side of the ring with a 4- to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)cycloalkenyl,which is condensed on one side of the ring with a 4- to 6-membered saturated or unsaturated carbocyclic ring, wherein each of the latter 4 residues is unsubstituted or by one or more residues from the group consisting of halogen, hydroxy, cyano, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy, (C1-C4)alkylthio, (C1-C4)alkylamino, di[(C1-C4)alkyl]amino, [(C1-C4)alkoxy]carbonyl, [(C1-C4)haloalkoxy]carbonyl, (C3-C6)cycloalkyl, which is unsubstituted or substituted, phenyl, which unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted, is substituted, or RH 3< means (C 1 -C 4 )-alkoxy, (C 2 -C 4 )alkenyloxy, (C 2 -C 6 )alkynyloxy or (C 2 -C 4 )haloalkoxy, and RH 4< means hydrogen or (C 1 -C 4 )-alkyl, or RH 3< and RH 4< together with the directly bonded N atom form a four- to eight-membered heterocyclic ring,which, in addition to the N atom, may also contain further heteroring atoms, preferably up to two further heteroring atoms from the group N, O and S, and which is unsubstituted or substituted by one or more residues from the group halogen, cyano, nitro, (C1-C4)alkyl, (C1-C4)haloalkyl, (C1-C4)alkoxy, (C1-C4)haloalkoxy and (C1-C4)alkylthio. S16) Active substances that are primarily used as herbicides, but also have a safener effect on cultivated plants, e.g. B. (2,4-Dichlorophenoxy)acetic acid (2,4-D), (4-Chlorphenoxy)acetic acid, (R,S)-2-(4-chloro-o-tolyloxy)propionic acid (Mecoprop), 4-(2,4-Dichlorophenoxy)butyric acid (2,4-DB), (4-Chloro-o-tolyloxy)acetic acid (MCPA), 4-(4-Chloro-o-tolyloxy)butyric acid, 4-(4-Chlorphenoxy)butyric acid, 3,6-Dichloro-2-methoxybenzoic acid (Dicamba), 1-(Ethoxycarbonyl)ethyl-3,6-dichloro-2-methoxybenzoate (Lactidichloro-ethyl). ,

[0059] Particularly preferred are solvent-free, water-dispersible technical concentrates (TCs) 0.5 to 40 wt.%, preferably 0.5 to 30 wt.%, particularly preferably 0.5 to 15 wt.% of component a), 2 to 35 wt.%, preferably 3 to 30 wt.%, preferably 5 to 25 wt.% and most preferably 10 to 20 wt.% of component b1), 0.1 to 10 wt.%, preferably 0.3 to 8 wt.% and most preferably 1 to 7 wt.% of component c1), 2 to 35 wt.%, preferably 3 to 30 wt.%, preferably 5 to 25 wt.% and most preferably 10 to 20 wt.% of component c2).

[0060] These are particularly preferably combined with an active ingredient e) from the herbicide group, preferably sulfonylureas such as mesosulfuron methyl (0.5-5 wt%), iodosulfuron methyl sodium or acid (0.05-10 wt%), amidosulfuron (0.5-5 wt%), HPPD (4-hydroxyphenylpyruvate dioxygenase) inhibitors, as well as other active ingredients from the ALS (acetolactate synthase) inhibitor group such as thiencarbazone methyl (0.2-5 wt%) and / or typical pigment bleaching agents such as diflufenican (2-20 wt%). Active ingredients based on iodosulfuron, amidosulfuron, and mesosulfuron are preferred.

[0061] Particularly preferably, kaolin or calcium carbonate in combination with silica is used as c2). Particularly preferably, precipitated silica is used as c1), and particularly preferably, calcium carbonate is combined with precipitated silica as c2).

[0062] Particularly preferred are the solvent-free, water-dispersible suspension concentrates containing 0.5 to 40 wt.%, preferably 0.5 to 30 wt.%, particularly preferably 0.5 to 15 wt.% of component a); 0.1 to 10 wt.%, preferably 0.2 to 7 wt.% and most preferably 0.3 to 4 wt.% of component b1); 1 to 15 wt.%, preferably 2 to 10 wt.% and most preferably 2.5 to 8 wt.% of component b2); 0.05 to 10 wt.%, preferably 0.1 to 8 wt.%, preferably 0.3 to 5 wt.% and most preferably 0.5 to 3 wt.% of component c1); 0.01 to 1.0 wt.%, particularly preferably 0.01 to 0.6 wt.%, most preferably 0.05 to 0.5 wt.% and most preferably 0.1 to 0.3 wt.% of component d1).

[0063] These are particularly preferably combined with an active ingredient e) from the herbicide group, preferably from the auxin group such as halauxifen-methyl (0.05-5 wt%) and / or from the pigment synthesis inhibitor group (pigment bleachers) such as diflufenican 5-30% and from the DOXP synthase inhibitor group such as clomazone, and preferably isoxazolidinones, 2-[(2,4-dichlorophenyl)methyl]-4,4-dimethyl- (CAS number 81777-95-9) and / or from the VLCFA inhibitor group (very long chain fatty acid, inhibition of cell division for the production of fatty acids) flufenacet (5-30 wt%). Halauxifen-methyl and / or diflufenican are preferably used.

[0064] Furthermore, the SCs or TKs or WGs according to the invention may optionally contain as further components f): wetting agents, pH adjusting agents, defoamers, biocides, disintering agents, adhesion promoters, antifreeze, preservatives, dyes or fertilizers, as well as various surfactants from component b).

[0065] Suitable defoamers are surface-active compounds based on silicone or silane, such as the Tegopren® products (Goldschmidt), the SE® products (Wacker), as well as the Bevaloid® (Kemira), Rhodorsil® (Solvay) and Silcolapse® products (Blustar Silicones). SE® (Wacker), Rhodorsil® and Silcolapse® products are preferred; products such as Silcolapse® 5020 are particularly preferred.

[0066] Suitable antifreeze agents are those from the group of ureas, diols and polyols, such as ethylene glycol and propylene glycol, glycerin preferably propylene glycol or glycerin.

[0067] Suitable preservatives include products such as Acticide ®< MBS (Biocide, Thor Chemie), CIT, MIT or BIT such as Proxel ®< GXL (BIT), Acticide ®< SPX (MIT, CIT).

[0068] Suitable wetting agents are selected from the group of naphthalenesulfonic acids and the group of sulfosuccinic acid derivatives, as well as the salts of these groups, which on the one hand contain mono- and diesters of sulfosuccinic acid and their salts (sulfosuccinates), and on the other hand contain alkylated naphthalenesulfonic acids and their salts, such as Aerosol® < OTB (dioctyl sulfosuccinate), Morwet® < EFW (alkylated naphthalenesulfonates), Nekal® < BX (alkylated naphthalenesulfonates), Galoryl® < MT 804 (alkylated naphthalenesulfonates).

[0069] Preferred wetting agents are the salts of alkylated naphthalenesulfonic acids and the salts of dioctylsulfobensuccinic acid, particularly preferably the sodium salts of alkylated naphthalenesulfonates such as Morwet® < EFW, and the sodium salts of dioctylsulfobensuccinic acid such as Aerosol® < OTB.

[0070] Suitable adhesion promoters can be selected from the group consisting of polyvinylpyrrolidone (PVP), polyvinyl alcohol, PVP-dimethylaminoethyl methacrylate copolymer, butylated PVP, vinyl chloride-vinyl acetate copolymer, sodium salt of the propensulfonic acid-partially hydrolyzed vinyl acetate copolymer, sodium caseinate, phenolic resins, and modified cellulose types such as Luviskol® (polyvinylpyrrolidone) and Mowiol® (polyvinyl alcohol).

[0071] Polyvinylpyrrolidone types are preferred, especially low molecular weight types such as Luviskol ®< K30.

[0072] Suitable disintegrants can be selected from the group of modified carbohydrates, such as microcrystalline cellulose and cross-linked polyvinylpyrrolidones, for example Avicel® < PH 101 (microcrystalline cellulose), Agrimer® < XLF (cross-linked polyvinylpyrrolidone), Disintex® < 200 (cross-linked polyvinylpyrrolidone). Cross-linked polyvinylpyrrolidones, such as Agrimer® < XLF, are preferred.

[0073] Suitable antifoaming agents can be selected from the group of phosphoric acid esters with lower alcohols, C6-C10 alcohols, silicone surfactants (suspoemulsions of hydrophobized silica particles in aqueous emulsion concentrates based on liquid silicone surfactants), such as polydimethylsiloxane, and their absorbates onto solid carrier materials, such as Rhodorsil® < 432 (silicone surfactant), butyl phosphate, isobutyl phosphate, n-octanol, Wacker ASP15 (polydimethylsiloxane, absorbed onto a solid carrier), and Antifoam Agent® < SE (polydimethylsiloxane). Suspoemulsions of hydrophobized silica particles in aqueous emulsion concentrates based on liquid silicone surfactants, such as Antifoam Agent® < SE (polydimethylsiloxane), and solid antifoam agents, such as Wacker ASP 15 (polydimethylsiloxane), are preferred.

[0074] Suitable emulsifiers, wetting agents, and dispersants include, for example, non-ionic emulsifiers and dispersants, e.g.: polyalkoxylated, preferably polyethoxylated, saturated and unsaturated aliphatic alcohols, with 8 to 24 C atoms in the alkyl group derived from the corresponding fatty acids or from petrochemical products, and with 1 to 100, preferably 2 to 50, ethylene oxide units (EO), wherein the free hydroxy group is optionally alkoxylated, e.g. Genapol®< X and Genapol®< O series (Clariant), Crovol®< M series (Croda) or Lutensol®< series (BASF); Polyalkoxylated, preferably polyethoxylated hydroxy fatty acids or hydroxy fatty acids containing glycerides, such as ricinine or castor oil with a degree of ethoxylation between 10 and 80, preferably 25 to 40, such as Emulsogen®< EL series (Clariant) or Agnique®< CSO series (BASF); polyalkoxylated, preferably polyethoxylated sorbitan esters, such as Atplus®< 309 F (Croda) or Alkamuls®< series (Solvay).

[0075] Preferred non-ionic emulsifiers and dispersants are, for example, polyethoxylated alcohols and polyethoxylated triglycerides containing hydroxy fatty acids.

[0076] Ionic emulsifiers and dispersants are also suitable, e.g.: Polyalkoxylated, preferably polyethoxylated, emulsifiers / dispersants that are ionically modified, e.g., by conversion of the terminal free hydroxyl function of the polyethylene oxide block to a sulfate or phosphate ester (e.g., as alkali and alkaline earth metal salts), such as Genapol® < LRO or Dispersing Agent 3618 (Clariant), Emulphor® < (BASF), or Crafol® < AP (BASF); alkali and alkaline earth metal salts of alkylarylsulfonic acids with a linear or branched alkyl chain, such as phenylsulfonate CA or phenylsulfonate CAL (Clariant), Atlox® < 3377BM (Croda), Empiphos® < TM series (Huntsman); Polyelectrolytes, such as polystyrene sulfonate or sulfonated unsaturated or aromatic polymers (polystyrenes, polybutadienes or polyterpenes).

[0077] The proportion of any other conventional auxiliary and additive materials f) added in the dispersions according to the invention can be up to 20 wt.%, preferably up to 15 wt.%.

[0078] The proportion of the component water in the dispersions according to the invention is 20 to 70 wt.%, preferably 20 to 60 wt.%, particularly preferably 30 to 55 wt.%, and most preferably 25 to 45 wt.%.

[0079] The invention further relates to a herbicidal agent which can be produced from the SC's, TK's or WG's according to the invention by dilution with liquids, preferably water.

[0080] It can be advantageous to add further active ingredients, preferably agrochemical active ingredients (e.g., as tank mix partners in the form of appropriate formulations) and / or excipients and additives commonly used in application, e.g., self-emulsifying oils such as vegetable oils or paraffin oils and / or fertilizers, to the herbicidal agents thus obtained. The present invention therefore also relates to such agents, preferably herbicidal agents, based on the formulations according to the invention.

[0081] A particular embodiment of the invention relates to the use of the herbicidal agents obtainable from the SCs, TKs or WGs according to the invention for controlling unwanted plant growth, hereinafter referred to as "herbicidal agent".

[0082] These herbicidal products exhibit excellent efficacy against a broad spectrum of economically important monocotyledonous and dicotyledonous weeds. Even difficult-to-control perennial weeds that sprout from rhizomes, rootstocks, or other dormant organs are effectively controlled. The herbicidal products can be applied, for example, by pre-sowing, pre-emergence, or post-emergence methods. The following are some examples of monocotyledonous and dicotyledonous weeds that can be controlled by these herbicidal products, without implying a limitation to specific species.

[0083] On the monocotyledonous weed side, for example Apera spica venti, Avena spp., Alopecurus spp., Brachiaria spp., Digitaria spp., Lolium spp., Echinochloa spp., Panicum spp., Phalaris spp., Poa spp., Setaria spp., as well as Bromus spp. such as Bromus catharticus, Bromus secalinus, Bromus erectus, Bromus tectorum and Bromus japonicus, and Cyperus species from the annual group, and on the perennial species side Agropyron, Cynodon, Imperata, as well as Sorghum and also perennial Cyperus species are well covered. In dicotyledonous weed species, the spectrum of activity extends to species such as Abutilon spp., Amaranthus spp., Chenopodium spp., Chrysanthemum spp., Galium spp. (including Galium aparine, Ipomoea spp.), Kochia spp., Lamium spp., Matricaria spp., Pharbitis spp., Polygonum spp., Sida spp., Sinapis spp., Solanum spp., Stellaria spp., Veronica spp. and Viola spp., Xanthium spp., on the annual side, as well as Convolvulus, Cirsium, Rumex and Artemisia among the perennial weeds.Under the specific growing conditions of rice, weeds such as Echinochloa, Sagittaria, Alisma, Eleocharis, Scirpus, and Cyperus are also effectively controlled by herbicides. If the herbicides are applied to the soil surface before germination, either the emergence of the weed seedlings is completely prevented, or the weeds grow to the cotyledon stage, then cease growth and finally die completely after three to four weeks.

[0084] When herbicidal agents are applied to the green parts of the plants using the post-emergence method, a drastic growth stop also occurs very quickly after treatment, and the weeds remain in the growth stage they were at at the time of application or die completely after a certain period of time, so that in this way harmful weed competition for the cultivated plants is eliminated very early and sustainably.

[0085] The herbicidal agents are characterized by a rapid onset and long-lasting herbicidal effect. The rainfastness of the active ingredients in the herbicidal agents is generally favorable. A particular advantage is that the effective dosages of herbicidal compounds used in the herbicidal agents can be adjusted so low that their soil activity is optimally minimized. This not only makes their use possible in sensitive crops but also virtually eliminates groundwater contamination. The combination of active ingredients according to the invention enables a significant reduction in the required application rate of the active ingredients.

[0086] The aforementioned properties and advantages are beneficial in practical weed control, helping to keep agricultural crops free of unwanted competing plants and thus securing and / or increasing yields in terms of both quality and quantity. These new herbicidal products significantly exceed current technical standards with regard to the described properties.

[0087] Although these herbicidal products exhibit excellent herbicidal activity against monocotyledonous and dicotyledonous weeds, cultivated plants of economically important crops, e.g., dicotyledonous crops such as soybeans, cotton, rapeseed, sugar beets, or grass crops such as wheat, barley, rye, oats, millet, rice, or maize, are only minimally affected or not at all. For these reasons, the herbicidal products available are very well suited for the selective control of unwanted plant growth in agricultural crops or ornamental plantings.

[0088] Furthermore, depending on the crop, the corresponding herbicidal agents exhibit excellent growth-regulating properties. They regulate the plant's own metabolism and can therefore be used to selectively influence plant constituents and facilitate harvesting, for example, by inducing desiccation and stunted growth. They are also potentially suitable for the general control and inhibition of unwanted vegetative growth without killing the plants. Inhibition of vegetative growth plays a significant role in many monocot and dicot crops, as it can reduce or completely prevent storage.

[0089] Due to their herbicidal and plant growth-regulating properties, herbicidal agents—as already mentioned—can also be used to control weeds in crops of known or yet-to-be-developed genetically modified plants. Transgenic plants are generally characterized by particularly advantageous properties, such as resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens such as certain insects or microorganisms like fungi, bacteria, or viruses. Other special properties relate, for example, to the harvested crop in terms of quantity, quality, storability, composition, and specific constituents. For instance, transgenic plants with increased starch content or altered starch quality, or those with a different fatty acid composition of the harvested crop, are known.

[0090] The application of these herbicidal agents is preferred in economically important transgenic crops of crops and ornamental plants, e.g., grass crops such as wheat, barley, rye, oats, millet, rice, and maize, or crops of sugar beet, cotton, soybeans, rapeseed, potatoes, tomatoes, peas, and other vegetables. The herbicidal agents can preferably be used in crops that are resistant to the phytotoxic effects of the herbicides or have been genetically engineered to be resistant.

[0091] When applying herbicidal agents in transgenic crops, in addition to the effects observed in other crops against weeds, effects often occur that are specific to the application in the respective transgenic crop, for example, an altered or specifically expanded weed spectrum that can be controlled, altered application rates that can be used, preferably good combinationability with the other herbicidal active ingredients to which the transgenic crop is resistant, as well as influencing the growth and yield of the transgenic crop plants.

[0092] A method for controlling unwanted plant growth, preferably in crops such as cereals (e.g., wheat, barley, rye, oats, rice, maize, millet), sugar beet, sugar cane, rapeseed, cotton, and soybeans, and particularly preferably in monocotyledonous crops such as cereals (e.g., wheat, barley, rye, oats), and hybrids thereof (e.g., triticale, rice, maize, and millet), is described herein but not claimed. This method is characterized in that the herbicidal agents according to the invention are applied to the unwanted plants, plant parts, plant seeds, or the area on which the plants grow (e.g., the cultivated area). The crops may also be genetically modified or obtained through mutation selection and are preferably tolerant to acetolactate synthase (ALS) inhibitors.

[0093] With the WGs and SCs according to the invention, a better biological effect can be achieved with the same application rate. Advantageously, the SCs, TKs, or WGs according to the invention exhibit excellent plant compatibility and a reduced tendency to cause phytotoxic damage.

[0094] In addition, the SCs, TKs or WGs according to the invention, as special active ingredient combination formulations (synonymous: mixture formulations, co-formulations), have further advantages, such as lower packaging costs than when using individual active ingredients, which simplifies the effort for production, transport and storage, and makes the preparation of the spray solutions used in agriculture easier to handle due to the smaller quantities and the already adjusted, effective ratios, e.g. during the measuring and mixing process.

[0095] The SCs, TKs or WGs according to the invention additionally exhibit surprisingly excellent dispersing and stabilizing properties after further dilution with liquids, preferably water.

[0096] In addition, the SC's, TK's or WG's result in formulations that are stable in long-term storage and technically sound.

[0097] Another preferred embodiment is the use of the SCs, TKs, or WGs according to the invention as growth regulators (phytotonics). These combinations are preferably used to improve the "greening" of the plant.

[0098] Plant growth regulators can exert various effects on plants. The effect of these substances depends primarily on the timing of application relative to the plant's developmental stage, as well as on the amounts of active ingredient applied to the plants or their environment, and on the application method. In any case, growth regulators should produce a specific desired effect on the cultivated plants.

[0099] Growth-regulating effects include earlier germination, better emergence, a more developed root system and / or improved root growth, increased tillering capacity, more productive tillers, earlier flowering, increased plant height and / or biomass, stem shortening, improvements in shoot growth, number of grains / ear, number of ears / m², number of stolons and / or number of flowers, increased harvest index, larger leaves, fewer dead basal leaves, improved phyllotaxia, earlier maturity / earlier fruit development, homogeneous maturity, increased grain filling time, better fruit development, larger fruit / vegetable size, shoot resistance, and reduced lodging.

[0100] Increased or improved yield refers to total biomass per hectare, yield per hectare, grain / fruit weight, seed size and / or hectoliter weight, as well as improved product quality, which includes the following: Improved processability with regard to size distribution (seed, fruit, etc.), homogeneous ripening, grain moisture, better milling, better winemaking, better brewing, increased juice yield, increased harvestability, increased digestibility, increased sedimentation value, increased falling number, increased pod stability, increased storage stability, improved fiber length / strength / uniformity, increased milk and / or meat quality from silage-fed animals, suitability for cooking and roasting; furthermore, comprehensively improved marketability with regard to increased fruit / grain quality, size distribution (seed, fruit, etc.), increased storability / shelf life, firmness / softness, taste (aroma, texture, etc.), class (size, shape, number of berries, etc.), number of berries / fruits per bunch, crispness, freshness, wax coating, frequency of physiological disorders, color, etc.; furthermore, comprehensively increased desirable constituents such as...Protein content, fatty acids, oil content, oil quality, amino acid composition, sugar content, acidity (pH value), sugar / acid ratio (Brix), polyphenols, starch content, nutritional value, gluten content / index, energy content, taste, etc.; and furthermore, comprehensively a reduction in undesirable components such as less mycotoxins, less aflatoxins, geosmin content, phenolic aromas, laccase, polyphenol oxidases and peroxidases, or nitrate content.

[0101] Plant growth regulators can be used, for example, to slow down the vegetative growth of plants. Such growth suppression is of economic interest, for instance, with grasses, as it makes it possible to reduce the frequency of mowing in ornamental gardens, parks and sports facilities, along roadsides, at airports, or in orchards. Inhibiting the growth of herbaceous and woody plants along roadsides and near pipelines or overhead cables, or more generally wherever vigorous plant growth is undesirable, is also important.

[0102] Also important is the use of growth regulators to inhibit the elongation of cereals. This reduces or completely eliminates the risk of lodging before harvest. Furthermore, growth regulators can strengthen the stems of cereals, which also counteracts lodging. Using growth regulators to shorten and strengthen the stems allows for the application of higher fertilizer quantities to increase yield without the risk of lodging.

[0103] In many cultivated plants, the suppression of vegetative growth allows for a greater plant density, and it is therefore possible to achieve higher yields in relation to the soil surface area.

[0104] Another advantage of the smaller plants obtained in this way is that they are easier to cultivate and harvest.

[0105] Reducing vegetative plant growth can also lead to increased or improved yields, as the nutrients and assimilates are of greater benefit for flower and fruit formation than for the vegetative parts of the plants.

[0106] Alternatively, growth regulators can also be used to promote vegetative growth. This is particularly useful when the vegetative parts of the plant are harvested. However, promoting vegetative growth can also stimulate generative growth by increasing the production of assimilates, resulting in more or larger fruits.

[0107] Furthermore, beneficial effects on growth or yield can be achieved through improved nutrient utilization, in particular nitrogen (N) utilization, phosphorus (P) utilization, water utilization, improved transpiration, respiration and / or CO2 assimilation rate, better nodule formation, improved Ca metabolism, etc.

[0108] Growth regulators can also be used to modify plant composition, which in turn can improve crop quality. Parthenocarpic fruits can be formed under the influence of growth regulators. Furthermore, it is possible to influence the sex of the flowers. It is also possible to produce sterile pollen, which is of great importance in breeding and producing hybrid seeds.

[0109] The use of growth regulators can control plant branching. On the one hand, breaking apical dominance can promote the development of side shoots, which can be highly desirable, especially in the cultivation of ornamental plants, even in combination with growth inhibition. On the other hand, however, the growth of side shoots can also be inhibited. This effect is of particular interest, for example, in the cultivation of tobacco or tomatoes.

[0110] Under the influence of growth regulators, the number of leaves on a plant can be controlled to achieve defoliation at a specific time. Such defoliation plays a crucial role in the mechanical harvesting of cotton, but it is also of interest for facilitating harvesting in other crops, such as viticulture. Defoliation can also be carried out to reduce the plants' transpiration before they are turned over.

[0111] Furthermore, growth regulators can modulate plant senescence, which can lead to a longer duration of green leaf area, a longer grain filling phase, improved yield quality, etc.

[0112] Growth regulators can also be used to control fruit drop. On the one hand, it is possible to prevent premature fruit drop. On the other hand, it is also possible to promote fruit drop, and even blossom shedding, to achieve a desired yield ("thinning"). Additionally, growth regulators can be applied at harvest time to reduce the force required to detach the fruit, thus facilitating mechanical harvesting or making hand harvesting easier.

[0113] Growth regulators can also be used to accelerate or delay the ripening of crops before or after harvest. This is particularly advantageous as it allows for optimal adjustment to market demands. Furthermore, growth regulators can, in some cases, improve fruit coloration. Additionally, they can be used to synchronize ripening within a specific timeframe. This enables complete mechanical harvesting or hand harvesting in a single operation, for example, with tobacco, tomatoes, or coffee.

[0114] The use of growth regulators also makes it possible to influence the seed or bud dormancy of plants in such a way that plants like pineapples or ornamental plants in nurseries, for example, germinate, sprout, or flower when they would not normally tend to do so. Where there is a risk of frost, it can be desirable to delay bud formation or seed germination with the help of growth regulators to avoid damage from late frosts.

[0115] Finally, growth regulators can induce resistance in plants to frost, drought, or high soil salinity. This allows plants to be cultivated in regions that are not normally suitable for this purpose.

[0116] The formulations according to the invention also exert a strong strengthening effect on plants. Accordingly, they can be used to mobilize the plant's defenses against infestation by unwanted microorganisms. In this context, plant-strengthening (resistance-inducing) substances are substances capable of stimulating the defense system of plants to such an extent that, when subsequently inoculated with unwanted microorganisms, the treated plants develop a high degree of resistance to these microorganisms.

[0117] Furthermore, plant physiological effects associated with the present invention include the following: tolerance of abiotic stress, including tolerance to high or low temperatures, drought tolerance and recovery after drought stress, water use (which is correlated with reduced water uptake), waterlogging tolerance, ozone stress and UV tolerance, tolerance to chemicals such as heavy metals, salts, pesticides, etc.

[0118] Tolerance to biotic stress, including increased fungal resistance and increased resistance to nematodes, viruses, and bacteria. In the context of the present invention, tolerance to biotic stress preferably includes increased fungal resistance and increased resistance to nematodes.

[0119] Increased plant growth, including plant health / plant quality and seed germination, reduced fallover, improved appearance, improved recovery after periods of stress, improved pigmentation (e.g. chlorophyll content, stay-green effects, etc.) and improved photosynthesis efficiency.

[0120] The use of the SCs, TKs or WGs according to the invention for increasing the resistance of plants to abiotic stress factors, preferably to drought stress, is described but not claimed.

[0121] The various benefits for plants mentioned above can, as is well known, be partially summarized and described using generally accepted terms. Such terms include, for example, the following: phytotonic effect, resistance to stress factors, reduced plant stress, plant health, healthy plants, plant fitness, plant wellness, plant concept, vigor effect, stress shield, protective shield, crop health, crop health properties, crop health products, crop health management, crop health therapy, plant health, greening effect (or re-greening effect), freshness, or other terms that are certainly familiar to experts.

[0122] A method for treating seeds is described, but not claimed. In the following, formulations according to the invention are collectively referred to as SCs, TKs, or WGs.

[0123] Another described, but not claimed, aspect relates in particular to seeds (in the dormant stage, after priming, pre-germinated, or even with developed roots and leaves) that have been treated with the formulations according to the invention. The described, but not claimed, seeds are used in processes for protecting seeds and plants that have developed from the seeds against phytopathogenic fungi. These processes utilize seeds that have been treated with formulations according to the invention.

[0124] The formulations according to the invention are also suitable for treating seeds and young seedlings. A large proportion of the damage to cultivated plants caused by pests is triggered by infection of the seeds before sowing or after germination. This phase is particularly critical because the roots and shoots of the growing plant are especially sensitive, and even minor damage can lead to the plant's death. Therefore, there is great interest in protecting the seeds and the germinating plants by using appropriate formulations.

[0125] It is also desirable to optimize the amount of active ingredient used to provide the best possible protection for seeds, germinating plants, and seedlings against infection by phytopathogenic fungi, without harming the plants themselves with the active ingredient. In particular, seed treatment procedures should take into account the intrinsic phenotypes of transgenic plants to achieve optimal protection of the seed and germinating plant with a minimum of pesticides used.

[0126] A method for protecting seeds, germinating plants, and seedlings against infestation by animal pests and / or phytopathogenic microorganisms by treating the seeds with a formulation according to the invention is described, but not claimed. The use of the formulation according to the invention for seed treatment to protect seeds, germinating plants, and seedlings against animal pests and / or phytopathogenic microorganisms is described, but not claimed. Seed treated with a formulation according to the invention for protection against animal pests and / or phytopathogenic microorganisms is also described, but not claimed.

[0127] One of the advantages of the present invention is that treating the seeds with these formulations protects not only the seeds themselves, but also the resulting plants after emergence, against animal pests and / or phytopathogenic microorganisms. In this way, immediate treatment of the crop at the time of sowing or shortly thereafter protects plants in the same way as seed treatment before sowing. It is also considered advantageous that the formulations according to the invention can be used specifically for transgenic seeds, in which case the plant growing from these seeds is capable of expressing a protein that is effective against pests, herbicide damage, or abiotic stress. Treating such seeds with formulations according to the invention, for example, an insecticidal protein, can lead to the control of certain pests.Surprisingly, another synergistic effect can be observed here, which further increases the effectiveness in protecting against infestation by pests, microorganisms, weeds or abiotic stress.

[0128] The formulations according to the invention are suitable for protecting seeds of any plant varieties used in agriculture, greenhouses, forestry, or horticulture. In particular, the seeds include seeds of cereals (such as wheat, barley, rye, millet, and oats), rapeseed, maize, cotton, soybeans, rice, potatoes, sunflowers, beans, coffee, beets (e.g., sugar beets and fodder beets), peanuts, vegetables (such as tomatoes, cucumbers, onions, and lettuce), lawns, and ornamental plants. The treatment of seeds of wheat, soybeans, rapeseed, maize, and rice is of particular importance. Wheat is especially preferred.

[0129] As also described below, the treatment of transgenic seeds with the formulations according to the invention is of particular importance. This applies to seeds of plants that contain at least one heterologous gene that permits the expression of a polypeptide or protein, e.g., with insecticidal properties. These heterologous genes in transgenic seeds can, for example, originate from microorganisms of the genera Bacillus, Rhizobium, Pseudomonas, Serratia, Trichoderma, Clavibacter, Glomus, or Gliocladium. These heterologous genes preferably originate from Bacillus sp., and in this case, the gene product is effective against the European corn borer and / or the western corn rootworm. Particularly preferably, the heterologous genes originate from Bacillus thuringiensis.

[0130] In connection with the present invention, the formulation according to the invention is applied to seeds either alone or in a suitable formulation. Preferably, the seeds are treated in a state in which they are sufficiently stable so that no damage occurs during the treatment. In general, seeds can be treated at any time between harvest and a certain period after sowing. It is customary to use seeds that have been separated from the plant and are free of cobs, husks, stems, hulls, hairs, or the flesh of the fruit. For example, it is possible to use seeds that have been harvested, cleaned, and dried to a moisture content of less than 15% by weight.Alternatively, it is also possible to use seeds that have been treated with water after drying and then dried again, or seeds immediately after priming, or seeds that have been stored in the post-priming state or as pre-germinated seeds, or seeds that have been sown on planting trays, tapes or paper.

[0131] The formulations according to the invention can be used to treat a wide variety of different types of seeds, either directly or after prior dilution with water. For example, the concentrates or the preparations obtainable from them by dilution with water can be used to treat seeds of cereals such as wheat, barley, rye, oats, and triticale, as well as seeds of maize, soybean, rice, rapeseed, peas, beans, cotton, sunflowers, and beets, or also a wide variety of vegetable seeds. The formulations according to the invention or their diluted preparations can also be used for seeds of transgenic plants. In this case, additional synergistic effects can occur through interaction with the substances formed by expression.

[0132] For treating seeds with the formulations according to the invention or their preparations produced by adding water, all mixing units that are commonly used for seed applications are suitable. Specifically, the procedure for seed applications consists of placing the seeds in a mixing device, adding the desired quantity of the formulations, either as such or after prior dilution with water, and then mixing everything until all applied formulations are homogeneously distributed on the seeds. Drying may follow.

[0133] The application rate of the formulations according to the invention can vary within a relatively wide range. It depends on the respective active ingredient content in the formulations and on the type of seed. The application rate of each individual active ingredient is typically between 0.001 and 15 g per kilogram of seed, preferably between 0.01 and 5 g per kilogram of seed.

[0134] Another described, but not claimed, embodiment is the use of the formulations according to the invention for seed treatment.

[0135] The invention is explained in more detail by the examples. Examples and comparative examples: Materials used:

[0136] The terms used in the following examples have the following meanings: Mefenpyr-diethyl Diethyl ( RS )-1-(2,4-dichlorophenyl)-5-methyl-2-pyrazoline-3,5-dicarboxylate, (Bayer CropScience AG), melting range 50-55°C Flufenacet 4'-Fluoro-N-isopropyl-2-(5-trifluoromethyl-1,3,4-thiadiazol-2-yloxy)acetanilide (Bayer CropScience AG) Iodosulfuron-methyl ({[5-Iodo-2-(methoxycarbonyl)phenyl] sulfonyl} carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl) azanide (Bayer CropScience AG) Mesosulfuron-methyl Methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-α-(methanesulfonamido)-p-toluate (Bayer CropScience AG) Diflufenican 2',4'-Difluoro-2-(α,α,α-trifluoro-m-tolyloxy)nicotinanilide (Bayer CropScience AG) Cloquintocet-mexyl (RS)-1-Methylhexyl (5-chloroquinolin-8yloxy)acetate, melting range 60-70°C Halauxifen-methyl Methyl 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylate (CAS number: 943831-98-9) Morwet ®< D-425 Naphthalenesulfonic acid-formaldehyde condensate sodium salt (Akzo Nobel) Morwet ®< IP Diisopropyl naphthalenesulfonic acid, sodium salt (Akzo Nobel) Pluronic® < PE 10500 Propylene oxide-ethylene oxide (PO-EO) block polymer (BASF) Citric acid polybasic organic acid Rhodopol ®< 23 Xanthan Derivative (Solvay) Silcolapse ®< 411 Silicone defoamer (Solvay) Silfoam® SE 2 Silicone defoamer (Wacker) Glycerin antifreeze Proxel® < GXL Preservatives (biocide, Proxel) Kaolin TEC1 Aluminum hydrosilicate Sipernat ®< 22S Precipitated silica Sokalan ®< K30 Polyvinylpyrrolidone, non-ionic dispersant Solvesso 200 ND Mineral oil, ExxonMobil, naphthalene-free Calsogen ®< 4814 Calcium dodecyl benzene sulphonate in 2-ethylhexanol (approx. 40%), Clariant Emulsogen ®< 3510 nonionic surfactant, n-butyl-PO-EO block oxalkylate, Clariant Testing and storage procedures:

[0137] All tests were performed according to the CIPAC methods commonly used in plant protection (CIPAC = Collaborative International Pesticides Analytical Council; www.cipac.org). Long-term storage was carried out according to CIPAC MT 46.3 at 8 weeks at 40°C. The terms used below have the following meanings. Unless otherwise stated, 1 % Tested in water (CIPAC D, 342 ppm water hardness) at 23°C. 0TW = Test result after zero days of storage; 8W40 = Test result of the accelerated storage test (8 weeks at 40°C) to verify the long-term stability of a formulation product; Suspendability = Active ingredient distribution in a 1% aqueous solution (100% = completely homogeneously distributed, 0% = completely sedimented); Values ​​< 100% lead to uneven product distribution after application; according to international requirements, formulation products must have values ​​> 60%; Suspendability 8W40 = Value after 8 weeks of storage at 40°C; D90 = Active ingredient particle size (laser scattering of 90% of all volume particles); D90 8W40 = Active ingredient particle size after storage test (8 weeks at 40°C); An increase in the values ​​indicates crystal growth, whereby an increase by a factor of 2 is usually still acceptable; more than a factor of 4 is unacceptable; Sediment = Values ​​> 10% indicate heavy sediment formation.Sediment can be shaken loose = Yes for acceptable; No for unusable formulation products, as active ingredients can no longer be transferred into a spray solution; Wet sieving = measure of possible filter clogging during spray application; Values ​​>0.1% on a 150 µm sieve and >0.2% on a 45 µm sieve (each based on the amount of formulation used) are unacceptable. Preparation of an aqueous suspension concentrate B:

[0138] To prepare the examples listed in Table 1, water at room temperature is first added. While stirring, components a) (and, if applicable, further active ingredients e) as well as the other components b), c), and f) are then added (in no particular order). Component a) is added warm (65°C in the case of mefenpyr-diethyl or 80°C in the case of cloquintocet-mexyl) and stirred for 2 to 24 hours until crystals form. This is followed by wet milling, for example, using a bead mill. Finally, the organic thickener (component d1) is added.

[0139] In an alternative method, water at 5°C is used instead of water at room temperature. The vessel is also cooled to 5°C. Pre-grinding is performed using a colloid mill. Crystallization was achieved within half an hour. This is followed by wet grinding, for example, using a bead mill. Table 1: Data is given in percent by weight, wt.% component Example No. 1 2 3 V3 V4 V5 a Mefenpyr-diethyl 1,15 27,27 1,15 27,27 27,27 a Cloquintocet-mexyl 1,15 e Diflufenican 15,3 15,3 15,3 e Halauxifen-methyl 1,15 1,15 1,15 e Flufenacet 25,4 25,4 25,4 b1 Morwet ®< D-425 1,0 1,0 1,0 1,0 1,0 1,0 b2 Pluronic® < PE 10500 5 5 5 5 5 5 f Citric acid 0,1 0,1 0,1 0,1 0,1 0,1 c1 Aerosil® < 200 0,5 0,5 0,5 0 0,5 d Rhodopol ®< 23 0,2 0,2 0,2 0,2 0,2 0 f Silcolapse ®< 411 0,5 0,5 0,5 0,5 0,5 0,5 f Glycerin 5 5 5 5 5 5 f Proxel® < GXL 0,18 0,18 0,18 0,18 0,18 0,18 Water 44,72 44,72 59,25 45,22 58,75 58,45 In total: 100 100 100 100 100 100 Examples for comparison:

[0140] In V3 compared to 1 and in V4 compared to 3, c1) is missing in each case. An amorphous mefenpyr-diethyl forms in the formulations, which cannot be processed further. The formulations are not stable for storage and had to be discarded. In V5 without the organic thickener d1), storage-unstable products also formed and were discarded. Stability of the aqueous dispersion:

[0141] The dispersions according to the invention exhibit excellent storage stability. They remain stable for at least 2 years at room temperature and for at least 3 months at 40°C without any discernible change. Table 2: Storage stability and other formulation properties of the suspension concentrates 1-3: Test method CIPAC testing standard Examples 1 2 3 chemical degradation of the active ingredient 8W40 internal analytical method no no no Sustainability 0TW % MT 184 95 96 100 Suspension capability 8W 40% MT 184 75 85 95 D90 in µm0TW MT 187 4 7 4 D90 in µm 8W40 MT 187 9 10 8 Sediment, 8W40 MT 148 no no no Wet sieving 45% 8W40 MT 185 0,02 0,02 0,02 Wet sieving 150% 8W40 MT 185 0,01 0,01 0,01

[0142] All formulations according to the invention exhibit very good storage stability. No amorphous active ingredient could be identified under the microscope. Production of a partial concentrate according to the invention A)

[0143] To prepare examples 4-6 and V2 listed in Table 2, water at room temperature is first added. The active ingredients e are then added while stirring (in the case of iodosulfuron, a reaction with NaOH (32%) to pH 8 is carried out). Components b1), b2), c1), c2), and f are then added. Component a) is then added warm (65°C in the case of mefenpyrdiethyl) and stirred for 2 to 24 hours until crystals form. Wet milling, for example using a bead mill, is then carried out. Production of a partial concentrate not according to the invention

[0144] To prepare example V1 shown in Table 2, water at room temperature is first added. The active ingredients e) are then added while stirring (in the case of iodosulfuron, a reaction with NaOH (32%) to pH 8) is carried out. Components b1), b2), c1), c2), and f) are then added. Component a) is dissolved in Solvesso® < 200 ND and added as a solution. Wet milling, for example using a bead mill, is then carried out. A suspoemulsion of dispersed solids e) and emulsified a) is formed.

[0145] The TK slurries obtained according to the invention in Examples 1 to 3 and in the non-inventive Example V1 are further processed to produce WG. Fluidized bed drying is carried out according to the prior art. Examples 1-3 are free of organic solvents; V1 still contains 16 wt% Solvesso® < 200 ND. Table 3: Technical Concentrates: (Data is given in percent by weight, wt.%) component 4 5 6 V1 a Mefenpyr-diethyl 6,25 6,25 6,25 6,25 e Iodosulfuron-methyl 1,2 1,2 1,2 1,2 e Mesosulfuron-methyl 3,59 3,59 3,59 3,59 b1 Morwet ®< D-425 12,5 12,5 12,5 12,5 b1 Morwet ®< IP 2,5 2,5 2,5 2,5 f NaOH (32%) 1,19 1,19 1,19 1,19 c1 Aerosil® < 200 5,0 5,0 c1 Sipernat ®< 22S 5,0 5,0 c2 Kaolin ®< TEC1 15,75 15,75 4,5 c2 CaCO3 15,75 b2 Sokalan ®< K 30 1,0 1,0 1,0 1,0 f Silfoam® SE 2 2,0 2,0 2,0 2,0 f Calsogen ®< 4814 1,62 f Emulsogen ®< 3510 1,39 Water 49,02 49,02 49,02 49,02 Solvesso® < 200 ND 8,25 In total: 100 100 100 100 Stability of the shared apartment:

[0146] The examples of water-dispersible granules (4WG-6WG and V1WG, respectively) produced according to the invention from the technical concentrates 4-6 and V1 exhibit excellent storage stability. They are stable for at least 2 years at room temperature and for at least 3 months at 40°C without any discernible change. Comparative example V1WG contains the undesired Solvesso® < 200 ND. Table 4: Storage stability and other formulation properties Test method CIPAC testing standard Examples 4 WG 5 WG 6 WG V1 WG chemical degradation of the active ingredient 8W40 internal analytical method no no no no Sustainability 0TW in % MT 184 71 56 79 93 Sustainability of 8W40 in % MT 184 constant constant constant constant

Claims

1. Process for producing aqueous formulations free of organic solvents, characterized in that at least one active agrochemical ingredient a) having a melting temperature range between 50°C and 80°C is first melted in a first step, then the melt is added to water while stirring, the water containing at least one ionic and / or nonionic dispersant b), and the mixture is cooled below the melting point of the active ingredient in a second step, characterized in that the active ingredient a) is mefenpyr-diethyl, and wherein in the first step component a) is added to an aqueous solution comprising an ionic dispersant b1) and a carrier material c1) and also a filler c2), and wherein the water has a temperature between 0°C and 40°C, and wherein, in the second step, the mixture is stirred during the cooling for a period of 5 minutes to 24 h, and wherein mefenpyr-diethyl crystals can be detected under the microscope to an extent of at least 90% by weight, based on mefenpyr-diethyl used, and the crystalline active ingredient no longer has an amorphous structure, and wherein c1) is selected from the group of the highly absorptive carriers having an absorption capacity of at least 200 g of dibutyl phthalate per 100 g of carrier material, wherein the highly adsorptive carrier is selected from the group of the silicas.

2. Process according to Claim 1, characterized in that, in a third step, the crystallized product is ground, with at least 50% of the particles having a size of 1 to 5 µm (d50, volume particles).

3. Technical concentrate (TC) obtainable by the process according to Claim 2.

4. Water-dispersible granules (WG) obtainable by the method according to Claim 1, characterized in that the water is removed after the third step, and wherein the granules are produced by fluidized bed methodology.

5. Solvent-free, water dispersible technical concentrates (TCs) obtainable by the method according to Claim 2, comprising - an active ingredient a) having a melting temperature range between 50 and 80°C, where the active ingredient a) is mefenpyr-diethyl, - one or more anionic emulsifiers b1), - one or more nonionic emulsifiers b2), - at least one or more than one carrier material c1) and - at least one filler c2).

6. Solvent-free, water-dispersible technical concentrates (TCs) according to Claim 3 or 5, characterized in that they comprise an active ingredient e) from the group of the sulfonylureas, the HPPD (4-hydroxyphenylpyruvate dioxygenase) inhibitors, from the group of the ALS (acetolactate synthase) inhibitors and / or typical pigment bleachers.

7. Solvent-free, water-dispersible suspension concentrates (SCs) according to Claim 6, characterized in that the active ingredient e) is selected from the group comprising mesosulfuron methyl, iodosulfuron-methyl-sodium or -acid, amidosulfuron, thiencarbazone-methyl or diflufenican.

8. Solvent-free, water-dispersible suspension concentrates (SCs) obtainable by the method according to Claim 2, comprising - an active ingredient a) having a melting temperature range between 50 and 80°C, where the active ingredient a) is mefenpyr-diethyl, - one or more anionic emulsifiers b1), - one or more nonionic emulsifiers b2), - a carrier material c1) and - at least one or more than one thickener d).

9. Solvent-free, water-dispersible suspension concentrates (SCs) according to Claim 8, characterized in that they comprise an active ingredient e) from the group of the auxins, from the group of the inhibitors of pigment synthesis, from the group of the DOXP synthase inhibitors and / or from the group of the VLCFA inhibitors.

10. Solvent-free, water-dispersible suspension concentrates (SCs) according to Claim 9, characterized in that the active ingredient e) is selected from the group comprising halauxifen-methyl, diflufenican, clomazone, isoxazolidinone, 2-[(2,4-dichlorophenyl)methyl] -4,4-dimethyl- (CAS Number 81777-95-9) or flufenacet.

11. Herbicidal composition obtainable from formulations produced by the process according to Claim 1 by dilution with water.